UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | Ä | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | V | W | X | Z
Number of items: 470.

A

Abeti, R; Duchen, MR; (2012) Activation of PARP by Oxidative Stress Induced by β-Amyloid: Implications for Alzheimer's Disease. Neurochemical Research 1 - 8.

Abeti, R; Duchen, MR; (2012) Activation of PARP by oxidative stress induced by β-amyloid: implications for Alzheimer's disease. Neurochem Res , 37 (11) 2589 - 2596. 10.1007/s11064-012-0895-x.

Acharya, S; Nagy, A; Budu, C; Treacy, C; Fearnley, J; Lees, AJ; ... Noyce, AJ; + view all (2012) The new bradykinesia akinesia incoordination (BRAIN) test: People with Parkinson's disease versus healthy controls. In: MOVEMENT DISORDERS. (pp. S102 - S102).

Ahmed, M; Miller, A; Hanna, MG; Greensmith, L; (2012) Investigating the effects of pharmacological up-regulation of the heat shock response in an in-vitro model of sporadic inclusion body myositis. In: NEUROMUSCULAR DISORDERS. (pp. S26 - S26).

Ahmed, Z; Asi, YT; Sailer, A; Lees, AJ; Houlden, H; Revesz, T; Holton, JL; (2012) The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol , 38 (1) 4 - 24. 10.1111/j.1365-2990.2011.01234.x.

Ahmed, Z; Revesz, T; Holton, JL; (2012) Neuropathology and pathophysiology of multiple system atrophy Response. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY , 38 (4) 381 - 381. 10.1111/j.1365-2990.2012.01266.x.

Alg, VS; Sofat, R; Houlden, H; Grieve, J; Watkins, LD; Werring, DJ; (2012) Genetic association studies of intracranial aneurysms: systematic review and meta-analysis in over 106 000 individuals. INTERNATIONAL JOURNAL OF STROKE , 7 8 - 8.

Andreasson, U; Portelius, E; Pannee, J; Zetterberg, H; Blennow, K; (2012) Multiplexing and multivariate analysis in neurodegeneration. Methods , 56 (4) 464 - 470. 10.1016/j.ymeth.2012.02.004.

Andreasson, U; Vanmechelen, E; Shaw, LM; Zetterberg, H; Vanderstichele, H; (2012) Analytical aspects of molecular Alzheimer's disease biomarkers. Biomark Med , 6 (4) 377 - 389. 10.2217/bmm.12.44.

Angel, TE; Jacobs, JM; Spudich, SS; Gritsenko, MA; Fuchs, D; Liegler, T; ... Smith, RD; + view all (2012) The cerebrospinal fluid proteome in HIV infection: change associated with disease severity. Clin Proteomics , 9 (1) 3 - ?. 10.1186/1559-0275-9-3.

Apaydin, H; Benbir, G; Lees, A; (2012) A Stimulus-Sensitive Tic Disorder Characterized by Echophenomena and Coprolalia. MOVEMENT DISORDERS , 27 (1) 159 - 160. 10.1002/mds.23952.

Aviles-Olmos, I; Kefalopoulou, Z; Djamshidian, A; Limousin, P; Dickson, J; Lees, A; Foltynie, T; (2012) An open label, single site, 12 month, phase II, randomised controlled trial evaluating the safety and efficacy of Exendin-4 (Exenatide) in the treatment of patients with moderate severity Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S109 - S109).

Ä

Änkö, ML; Müller-McNicoll, M; Brandl, H; Curk, T; Gorup, C; Henry, I; ... Neugebauer, KM; + view all (2012) The RNA-binding landscapes of two SR proteins reveal unique functions and binding to diverse RNA classes. Genome Biol , 13 (3) R17 - ?. 10.1186/gb-2012-13-3-r17.

B

Bartlett, JW; Frost, C; Mattsson, N; Skillbäck, T; Blennow, K; Zetterberg, H; Schott, JM; (2012) Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges. Biomark Med , 6 (4) 391 - 400. 10.2217/bmm.12.49.

Baruch, N; Duchen, M; Hanna, MG; (2012) Muscle degeneration in ion channel dysfunction. In: NEUROMUSCULAR DISORDERS. (pp. S16 - S16).

Beall, C; Hamilton, DL; Gallagher, J; Logie, L; Wright, K; Soutar, MP; ... Ashford, ML; + view all (2012) Mouse hypothalamic GT1-7 cells demonstrate AMPK-dependent intrinsic glucose-sensing behaviour. Diabetologia , 55 (9) 2432 - 2444. 10.1007/s00125-012-2617-y.

Bech, S; Hjermind, LE; Salvesen, L; Nielsen, JE; Heegaard, NH; Jørgensen, HL; ... Winge, K; + view all (2012) Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes. Parkinsonism Relat Disord , 18 (1) 69 - 72. 10.1016/j.parkreldis.2011.08.012.

Bendlin, BB; Carlsson, CM; Johnson, SC; Zetterberg, H; Blennow, K; Willette, AA; ... Sager, MA; + view all (2012) CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease. PLoS One , 7 (6) , Article e37720. 10.1371/journal.pone.0037720. Green and gold open access
file

Benilova, I; Karran, E; De Strooper, B; (2012) The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci , 15 (3) 349 - 357. 10.1038/nn.3028.

BenMoyal-Segal, L; Soreq, L; Ben-Shaul, Y; Ben-Ari, S; Ben-Moshe, T; Aviel, S; ... Soreq, H; + view all (2012) Adaptive Alternative Splicing Correlates with Less Environmental Risk of Parkinsonism. Neurodegenerative Diseases , 9 (2) 87 - 98. 10.1159/000331328.

Bettencourt, C; Bruges-Armas, J; Lima, M; Raposo, M; Ros, R; Montiel, R; (2012) Transcript Diversity of Machado-Joseph Disease Gene (ATXN3) Is Not Directly Determined by SNPs in Exonic or Flanking Intronic Regions. Journal of Molecular Neuroscience 1 - 5. 10.1007/s12031-012-9832-3.

Bettencourt, C; Kazachkova, N; Sequeiros, J; Bruges-Armas, J; Lima, M; Raposo, M; ... Jardim, LB; + view all (2012) Sequence analysis of 5′ regulatory regions of the Machado-Joseph disease gene (ATXN3). Cerebellum , 11 (4) 1045 - 1050. 10.1007/s12311-012-0373-7.

Bettencourt, C; Lima, M; (2012) Genetics at Different Levels in Machado-Joseph Disease (MJD/SCA3): Cause, Modifiers and Therapy. In: Hong, S, (ed.) Ataxia: Causes, Symptoms and Treatment. (123 - 138). Nova Science Publishers: New York.

Bettencourt, C; Lima, M; Garcia de Yebenes, J; (2012) The increasing number of SCA loci: contributes from classical genetics and new genomics. In: Almeirão, E and Honrado, T, (eds.) Neuropathology: New Research. (75 - 92). Nova Science Publishers: New York.

Bettencourt, C; Ros, R; Ampuero, I; de Yébenes, JG; Quintáns, B; Yáñez, Z; ... Pascual, SI; + view all (2012) Revisiting genotype-phenotype overlap in neurogenetics: Triplet-repeat expansions mimicking spastic paraplegias. Human Mutation , 33 (9) 1315 - 1323. 10.1002/humu.22148.

Bezprozvanny, I; Supnet, C; Sun, S; Zhang, H; De Strooper, B; (2012) Response to Shilling et al. (10.1074/jbc.M111.300491). J Biol Chem , 287 (24) 20469 - ?. 10.1074/jbc.L112.356790.

Blennow, K; Hardy, J; Zetterberg, H; (2012) The neuropathology and neurobiology of traumatic brain injury. Neuron , 76 (5) 886 - 899. 10.1016/j.neuron.2012.11.021.

Blennow, K; Zetterberg, H; Fagan, AM; (2012) Fluid biomarkers in Alzheimer disease. Cold Spring Harb Perspect Med , 2 (9) a006221 - ?. 10.1101/cshperspect.a006221.

Blennow, K; Zetterberg, H; Rinne, JO; Salloway, S; Wei, J; Black, R; ... AAB-001 201/202 Investigators,; + view all (2012) Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. Arch Neurol , 69 (8) 1002 - 1010. 10.1001/archneurol.2012.90.

Borgegård, T; Gustavsson, S; Nilsson, C; Parpal, S; Klintenberg, R; Berg, AL; ... Lundkvist, J; + view all (2012) Alzheimer's disease: presenilin 2-sparing γ-secretase inhibition is a tolerable Aβ peptide-lowering strategy. J Neurosci , 32 (48) 17297 - 17305. 10.1523/JNEUROSCI.1451-12.2012.

Brady, S; Squier, W; Hilton-Jones, D; Sewry, C; Hanna, M; Holton, JL; (2012) A histological evaluation of protein accumulation in inflammatory myopathies. In: NEUROMUSCULAR DISORDERS. (pp. S27 - S27).

Brady, S; Squier, W; Hilton-Jones, D; Sewry, C; Holton, JL; (2012) INCLUSION BODY MYOSITIS: A DIAGNOSTIC CHALLENGE. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Bras, J; Guerreiro, R; Hardy, J; (2012) Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nat Rev Neurosci , 13 (7) 453 - 464. 10.1038/nrn3271.

Bras, J; Verloes, A; Schneider, SA; Mole, SE; Guerreiro, RJ; (2012) Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Human Molecular Genetics , 21 (12) 2646 - 2650. 10.1093/hmg/dds089. Green and gold open access
filefile

Brinkmalm, G; Portelius, E; Öhrfelt, A; Mattsson, N; Persson, R; Gustavsson, MK; ... Brinkmalm, A; + view all (2012) An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid. J Mass Spectrom , 47 (5) 591 - 603. 10.1002/jms.2987.

Bromander, S; Anckarsäter, R; Kristiansson, M; Blennow, K; Zetterberg, H; Anckarsäter, H; Wass, CE; (2012) Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study. J Neuroinflammation , 9 242 - ?. 10.1186/1742-2094-9-242.

Brouillette, J; Caillierez, R; Zommer, N; Alves-Pires, C; Benilova, I; Blum, D; ... Buée, L; + view all (2012) Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model. J Neurosci , 32 (23) 7852 - 7861. 10.1523/JNEUROSCI.5901-11.2012.

Bruno, D; Pomara, N; Nierenberg, J; Ritchie, JC; Lutz, MW; Zetterberg, H; Blennow, K; (2012) Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants. Exp Gerontol , 47 (5) 347 - 352. 10.1016/j.exger.2011.09.008.

Buchhave, P; Minthon, L; Zetterberg, H; Wallin, AK; Blennow, K; Hansson, O; (2012) Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry , 69 (1) 98 - 106. 10.1001/archgenpsychiatry.2011.155.

Burge, J; Schorge, S; Hanna, MG; (2012) Progesterone reduces and shifts the voltage dependence of the skeletal muscle chloride conductance. In: NEUROMUSCULAR DISORDERS. (pp. S16 - S16).

Burge, JA; Hanna, MG; (2012) Novel insights into the pathomechanisms of skeletal muscle channelopathies. Curr Neurol Neurosci Rep , 12 (1) 62 - 69. 10.1007/s11910-011-0238-3.

Burke, A; Mantuano, E; Bhatia, KP; Veneziano, L; Giunti, P; (2012) NOVEL DE NOVO MUTATION CAUSING BENIGN HEREDITARY CHOREA WITH HYPOTHRYOIDISM AND A PITUITARY MASS. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. A11 - A11).

C

Cai, J; Qi, X; Kociok, N; Skosyrski, S; Emilio, A; Ruan, Q; ... Boulton, ME; + view all (2012) β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment. EMBO Mol Med , 4 (9) 980 - 991. 10.1002/emmm.201101084.

Camargos, S; Cardoso, F; Lees, AJ; Singleton, A; (2012) DYT16: The original cases. Journal of Neurology, Neurosurgery and Psychiatry , 83 (10) 1012 - 1014. 10.1136/jnnp-2012-302841.

Camargos, S; Lees, AJ; Singleton, A; Cardoso, F; (2012) DYT16: the original cases. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (10) 1012 - 1014. 10.1136/jnnp-2012-302841.

Cambray, S; Arber, C; Little, G; Dougalis, AG; de Paola, V; Ungless, MA; ... Rodríguez, TA; + view all (2012) Activin induces cortical interneuron identity and differentiation in embryonic stem cell-derived telencephalic neural precursors. Nature Communications , 3 841 - 841. 10.1038/ncomms1817.

Cantó, E; Reverter, F; Morcillo-Suárez, C; Matesanz, F; Fernández, O; Izquierdo, G; ... Comabella, M; + view all (2012) Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis. Mult Scler , 18 (7) 983 - 990. 10.1177/1352458511433063.

Cardoso, F; Vale, T; Lees, A; (2012) Gowers' Queen Square Case Notes on Chorea. In: NEUROLOGY.

Carmeliet, P; De Strooper, B; (2012) Alzheimer's disease: A breach in the blood-brain barrier. Nature , 485 (7399) 451 - 452. 10.1038/485451a.

Casas, JP; Hingorani, AD; (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet , 379 (9822) 1214 - 1224. 10.1016/S0140-6736(12)60110-X. Green and gold open access
file

Castro-Seoane, R; Hummerich, H; Sweeting, T; Tattum, MH; Linehan, JM; Fernandez de Marco, M; ... Klöhn, PC; + view all (2012) Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection. PLoS Pathogens , 8 (2) , Article e1002538 . 10.1371/journal.ppat.1002538. Green and gold open access
file

Chan, MV; Bubb, KJ; Noyce, A; Villar, IC; Duchene, J; Hobbs, AJ; ... Ahluwalia, A; + view all (2012) Distinct endothelial pathways underlie sexual dimorphism in vascular auto-regulation. Br J Pharmacol , 167 (4) 805 - 817. 10.1111/j.1476-5381.2012.02012.x.

Charlesworth, G; Gandhi, S; Bras, JM; Barker, RA; Burn, DJ; Chinnery, PF; ... Wood, NW; + view all (2012) Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiol Aging , 33 (4) 838.e7 - 838.11. 10.1016/j.neurobiolaging.2011.11.001.

Charlesworth, G; Gandhi, S; Bras, JM; Gentleman, SM; Guerreiro, R; Hardy, J; ... Wood, NW; + view all (2012) First stage association analysis of neuropatholically proven PD confirms MAPT as an independent risk factor for PD. In: MOVEMENT DISORDERS. (pp. S450 - S451).

Charlesworth, G; Gandhi, S; Bras, JM; Guerreiro, R; Hardy, J; Sheerin, U-M; ... Morris, H; + view all (2012) Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiology of Aging , 33 (4) 10.1016/j.neurobiolaging.2011.11.001.

Charlesworth, G; Plagnol, V; Holmström, KM; Bras, J; Sheerin, UM; Preza, E; ... Wood, NW; + view all (2012) Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. The American Journal of Human Genetics , 91 (6) 1041 - 1050. 10.1016/j.ajhg.2012.10.024. Green and gold open access
file

Chávez-Gutiérrez, L; Bammens, L; Benilova, I; Vandersteen, A; Benurwar, M; Borgers, M; ... De Strooper, B; + view all (2012) The mechanism of γ-Secretase dysfunction in familial Alzheimer disease. EMBO J , 31 (10) 2261 - 2274. 10.1038/emboj.2012.79.

Chung, HY; Machado, P; van der Heijde, D; D'Agostino, MA; Dougados, M; (2012) Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis , 71 (6) 809 - 816. 10.1136/annrheumdis-2011-200180.

Clark, CN; Weber, YW; Lerche, H; Warner, TT; (2012) Paroxysmal exercise-induced dyskinesia of the hands. Mov Disord , 27 (12) 1579 - 1580. 10.1002/mds.25200.

Connick, P; Kolappan, M; Crawley, C; Webber, DJ; Patani, R; Michell, AW; ... Chandran, S; + view all (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol , 11 (2) 150 - 156. 10.1016/S1474-4422(11)70305-2.

Cooper-Knock, J; Hewitt, C; Highley, JR; Brockington, A; Milano, A; Man, S; ... Shaw, PJ; + view all (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain , 135 (3) 751 - 764. 10.1093/brain/awr365. Green and gold open access
file

Coppola, G; Chinnathambi, S; Lee, JJ; Dombroski, BA; Baker, MC; Soto-Ortolaza, AI; ... Geschwind, DH; + view all (2012) Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet , 21 (15) 3500 - 3512. 10.1093/hmg/dds161.

Cortese, A; Machado, P; Miller, A; Brady, S; Hilton-Jones, D; Morrow, J; ... Hanna, M; + view all (2012) CLINICAL FEATURES AND CLINICAL COURSE OF SPORADIC INCLUSION BODY MYOSITIS (IBM): A PROSPECTIVE COHORT STUDY: IBM-NET. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Cortese, A; Machado, P; Morrow, J; Dewar, L; Hiscock, A; Miller, A; ... Hanna, MG; + view all (2012) The natural history of sporadic inclusion body myositis: data from the IBM-Net prospective cohort study. In: NEUROMUSCULAR DISORDERS. (pp. S27 - S27).

Costa, C; Arrambide, G; Tintore, M; Castilló, J; Sastre-Garriga, J; Tur, C; ... Montalban, X; + view all (2012) Value of NMO-IgG determination at the time of presentation as CIS. Neurology , 78 (20) 1608 - 1611. 10.1212/WNL.0b013e3182563b32.

Cottenie, E; Laura, M; Hanna, M; Dick, D; Blake, J; Houlden, H; Reilly, MM; (2012) Genetic analysis of FIG4 in patients with CMT. In: NEUROMUSCULAR DISORDERS. (pp. S18 - S18).

Crehan, H; Hardy, J; Pocock, J; (2012) Microglia, Alzheimer's disease, and complement. Int J Alzheimers Dis , 2012 983640 - ?. 10.1155/2012/983640. Gold open access

Crehan, H; Holton, P; Wray, S; Pocock, J; Guerreiro, R; Hardy, J; (2012) Complement receptor 1 (CR1) and Alzheimer's disease. Immunobiology , 217 (2) 244 - 250. 10.1016/j.imbio.2011.07.017.

Cremades, N; Cohen, SI; Deas, E; Abramov, AY; Chen, AY; Orte, A; ... Klenerman, D; + view all (2012) Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell , 149 (5) 1048 - 1059. 10.1016/j.cell.2012.03.037.

Curtis, HJ; Sibley, CR; Wood, MJ; (2012) Mirtrons, an emerging class of atypical miRNA. Wiley Interdiscip Rev RNA , 3 (5) 617 - 632. 10.1002/wrna.1122.

D

Daborg, J; Andreasson, U; Pekna, M; Lautner, R; Hanse, E; Minthon, L; ... Zetterberg, H; + view all (2012) Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease. J Neural Transm , 119 (7) 789 - 797. 10.1007/s00702-012-0797-8.

Dale, RC; Gardiner, A; Antony, J; Houlden, H; (2012) Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine. Dev Med Child Neurol , 54 (10) 958 - 960. 10.1111/j.1469-8749.2012.04394.x.

Davidson, G; Murphy, S; Polke, J; Laura, M; Salih, M; Muntoni, F; ... Reilly, M; + view all (2012) Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort. J Neurol , 259 (8) 1673 - 1685. 10.1007/s00415-011-6397-y.

De Strooper, B; Iwatsubo, T; Wolfe, MS; (2012) Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease. Cold Spring Harb Perspect Med , 2 (1) a006304 - ?. 10.1101/cshperspect.a006304.

De Strooper, B; Scorrano, L; (2012) Close encounter: mitochondria, endoplasmic reticulum and Alzheimer's disease. EMBO J , 31 (21) 4095 - 4097. 10.1038/emboj.2012.279.

De Strooper, B; Voet, T; (2012) Alzheimer's disease: A protective mutation. Nature , 488 (7409) 38 - 39. 10.1038/488038a.

Devine, MJ; Kaganovich, A; Ryten, M; Mamais, A; Trabzuni, D; Manzoni, C; ... Lewis, PA; + view all (2012) Correction: Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue. PLOS ONE , 7 (1) , Article e22489. 10.1371/annotation/c12e4f9e-5aae-424b-a69f-fddf16976dc5. Green and gold open access
file

Dihanich, S; (2012) MASL1: a neglected ROCO protein. Biochem Soc Trans , 40 (5) 1090 - 1094. 10.1042/BST20120127.

Ding, S; Riddoch-Contreras, J; Abramov, AY; Qi, Z; Duchen, MR; (2012) Erratum to: Mild stress of caffeine increased mtDNA content in skeletal muscle cells: the interplay between Ca(2+) transients and nitric oxide. J Muscle Res Cell Motil , 33 (5) 339 - ?. 10.1007/s10974-012-9327-4.

Ding, S; Riddoch-Contreras, J; Abramov, AY; Qi, Z; Duchen, MR; (2012) Mild stress of caffeine increased mtDNA content in skeletal muscle cells: the interplay between Ca2+ transients and nitric oxide. J Muscle Res Cell Motil , 33 (5) 327 - 337. 10.1007/s10974-012-9318-5.

Djamshidian, A; Lees, A; (2012) Impulsive compulsive behaviours in patients with Parkinson's disease treated with dopamine agonists. Focus on Parkinson's Disease , 23 (1) 16 - 21.

Djamshidian, A; O'Sullivan, SS; Lees, A; Averbeck, BB; (2012) Effects of dopamine on sensitivity to social bias in Parkinson's disease. PLoS One , 7 (3) , Article e32889 . 10.1371/journal.pone.0032889. Green and gold open access
file

Djamshidian, A; O'Sullivan, SS; Lees, AJ; Averbeck, BB; (2012) Effects of dopamine on sensitivity to social bias in Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S268 - S268).

Djamshidian, A; O'Sullivan, SS; Sanotsky, Y; Sharman, S; Matviyenko, Y; Foltynie, T; ... Averbeck, BB; + view all (2012) Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions? Mov Disord , 27 (9) 1137 - 1145. 10.1002/mds.25105.

Djamshidian, A; O'Sullivan, SS; Sanotsky, Y; Sharman, S; Matviyenko, Y; Foltynie, T; ... Averbeck, BB; + view all (2012) Decision making, impulsivity, and addictions: Do Parkinson's disease patients jump to conclusions? MOVEMENT DISORDERS , 27 (9) 1137 - 1145. 10.1002/mds.25105.

Dobricic, V; Stefanova, E; Jankovic, M; Gurunlian, N; Novakovic, I; Hardy, J; ... Guerreiro, R; + view all (2012) Genetic testing in familial and young-onset Alzheimer's disease: mutation spectrum in a Serbian cohort. Neurobiol Aging , 33 (7) 1481.e7 - 1481.12. 10.1016/j.neurobiolaging.2011.12.007.

Doherty, KM; Noyce, AJ; Silveira-Moriyama, L; Nisbet, A; Quinn, N; Lees, AJ; (2012) Familial camptocormia: from dystonia to myopathy. J Neurol Neurosurg Psychiatry , 83 (3) 350 - 351. 10.1136/jnnp.2011.246561.

Doherty, KM; Silveira-Moriyama, L; Bhatia, KP; Parton, M; Lees, AJ; Giladi, N; (2012) Camptocormia: Don't forget muscle disease in the movement disorder clinic. Journal of Neurology , 259 (8) 1752 - 1754. 10.1007/s00415-012-6448-z.

Doherty, KM; Silveira-Moriyama, L; Giladi, N; Bhatia, KP; Parton, M; Lees, AJ; (2012) Camptocormia: don't forget muscle disease in the movement disorder clinic. J Neurol , 259 (8) 1752 - 1754. 10.1007/s00415-012-6448-z.

Doherty, KM; Silveira-Moriyama, L; Nisbet, A; Noyce, A; Quinn, N; Parton, M; Lees, AJ; (2012) CAMPTOCORMIA: WHAT IS THE CAUSE? In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Doherty, KM; Silveira-Moriyama, L; Parkkinen, L; Healy, D; Farrell, M; Mencacci, NE; ... Holton, JL; + view all (2012) A clinicopathological study of parkin-linked parkinsonism - A study of 5 cases and comparison with Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S453 - S453).

Domijan, AM; Kovac, S; Abramov, AY; (2012) Impact of fumonisin B1 on glutamate toxicity and low magnesium-induced seizure activity in neuronal primary culture. Neuroscience , 202 10 - 16. 10.1016/j.neuroscience.2011.12.005.

Dubois, B; Tolosa, E; Katzenschlager, R; Emre, M; Lees, AJ; Schumann, G; ... Moline, ML; + view all (2012) Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study. MOVEMENT DISORDERS , 27 (10) 1230 - 1238. 10.1002/mds.25098.

Duran, R; Hardy, J; McNeill, A; Schapira, AHV; Mehta, A; Hughes, D; ... Deegan, P; + view all (2012) Novel pathogenic mutations in the glucocerebrosidase locus. Molecular Genetics and Metabolism , 106 (4) 495 - 497. 10.1016/j.ymgme.2012.05.006.

Duran, R; McNeill, A; Mehta, A; Hughes, D; Cox, T; Deegan, P; ... Hardy, J; + view all (2012) Novel pathogenic mutations in the glucocerebrosidase locus. Mol Genet Metab , 106 (4) 495 - 497. 10.1016/j.ymgme.2012.05.006. Gold open access

E

Eadie, MJ; Scott, AEM; Lees, AJ; Woodward, M; (2012) William Gowers: the never completed third edition of the 'Bible of Neurology'. BRAIN , 135 3178 - 3188. 10.1093/brain/aws181.

Eatough, V; Shaw, K; Lees, A; (2012) Banking on brains: Insights of brain donor relatives and friends from an experiential perspective. PSYCHOLOGY & HEALTH , 27 (11) 1271 - 1290. 10.1080/08870446.2012.669480.

Englund, E; Gustafson, L; Passant, U; Majounie, E; Renton, AE; Traynor, BJ; ... Hardy, J; + view all (2012) Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion. NEUROBIOLOGY OF AGING , 33 (8) , Article ARTN 1850.e13. 10.1016/j.neurobiolaging.2012.02.019.

Esselens, C; Sannerud, R; Gallardo, R; Baert, V; Kaden, D; Serneels, L; ... Annaert, W; + view all (2012) Peptides based on the presenilin-APP binding domain inhibit APP processing and Aβ production through interfering with the APP transmembrane domain. FASEB J , 26 (9) 3765 - 3778. 10.1096/fj.11-201368.

Everett, CM; Kara, E; Maresh, KE; Houlden, H; (2012) Clinical variability and L-Dopa responsive Parkinsonism in hereditary spastic paraplegia 11. Journal of Neurology , 259 (12) 2726 - 2728. 10.1007/s00415-012-6642-z.

Everett, CM; Kara, E; Maresh, KE; Houlden, H; (2012) Clinical variability and L-Dopa responsive Parkinsonism in hereditary spastic paraplegia 11. J Neurol , 259 (12) 2726 - 2728. 10.1007/s00415-012-6642-z.

F

Fahlke, C; Berggren, U; Berglund, KJ; Zetterberg, H; Blennow, K; Engel, JA; Balldin, J; (2012) Neuroendocrine assessment of serotonergic, dopaminergic, and noradrenergic functions in alcohol-dependent individuals. Alcohol Clin Exp Res , 36 (1) 97 - 103. 10.1111/j.1530-0277.2011.01598.x.

Fassone, E; Taanman, JW; Sweeney, MG; Woodward, C; Hargreaves, IP; Hanna, MG; ... Rahman, S; + view all (2012) WHOLE EXOME SEQUENCING REVEALS THAT SUBUNIT MUTATIONS ARE PREVALENT IN COMPLEX I DEFICIENT LEIGH SYNDROME. In: JOURNAL OF INHERITED METABOLIC DISEASE. (pp. S13 - S13).

Fawcett, KA; Murphy, SM; Polke, JM; Manji, H; Quinlivan, RM; Reilly, MM; ... Zdebik, AA; + view all (2012) Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls. Journal of Neurology, Neurosurgery and Psychiatry , 83 (12) 1204 - 1209. 10.1136/jnnp-2012-303055.

Fawcett, KA; Murphy, SM; Polke, JM; Wray, S; Burchell, VS; Manji, H; ... Houlden, H; + view all (2012) Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls. J Neurol Neurosurg Psychiatry , 83 (12) 1204 - 1209. 10.1136/jnnp-2012-303055.

Ferrari, R; Mok, K; Moreno, JH; Cosentino, S; Goldman, J; Pietrini, P; ... Momeni, P; + view all (2012) Screening for C9ORF72 repeat expansion in FTLD. Neurobiol Aging , 33 (8) 1850.e1 - 1850.11. 10.1016/j.neurobiolaging.2012.02.017.

Ferrari, R; Moreno, JH; Momeni, P; Mok, K; Hardy, J; Cosentino, S; ... Ghetti, B; + view all (2012) Screening for C9ORF72 repeat expansion in FTLD. Neurobiology of Aging , 33 (8) 10.1016/j.neurobiolaging.2012.02.017.

Fitzgerald, JC; Camprubi, MD; Dunn, L; Wu, HC; Ip, NY; Kruger, R; ... Plun-Favreau, H; + view all (2012) Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function. Cell Death Differ , 19 (2) 257 - 266. 10.1038/cdd.2011.90.

Foley, AR; Broomfield, AA; Pandraud, A; Johnson, JO; Singleton, AB; Hargreaves, IP; ... Muntoni, F; + view all (2012) High-dose riboflavin therapy in Brown-Vialetto-Van Laere syndrome: clinical and biochemical improvement. In: NEUROMUSCULAR DISORDERS. (pp. S4 - S4).

Fonteyn, EMR; Schmitz-Hubsch, T; Verstappen, CC; Baliko, L; Boesch, S; Bunn, L; ... van de Warrenburg, BPC; + view all (2012) Prospective analysis of falls in spinocerebellar ataxias. In: MOVEMENT DISORDERS. (pp. S182 - S182).

Foulds, PG; Yokota, O; Thurston, A; Davidson, Y; Ahmed, Z; Holton, J; ... Mann, DM; + view all (2012) Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. Neurobiology of Disease , 45 (1) 188 - 195. 10.1016/j.nbd.2011.08.003. Green and gold open access
file

Friedland, RP; Shah, JJ; Rebolledo-Mendez, JD; Farrer, LA; Vardarajan, B; Mok, K; Hardy, J; (2012) Behavioral variant frontotemporal lobar degeneration with amyotrophic lateral sclerosis with a chromosome 9p21 hexanucleotide repeat. Frontiers in Neurology , OCT 10.3389/fneur.2012.00136. Gold open access

Fugate, JE; Ameriso, SF; Ortiz, G; Schottlaender, LV; Wijdicks, EF; Flemming, KD; Rabinstein, AA; (2012) Variable presentations of postpartum angiopathy. Stroke , 43 (3) 670 - 676. 10.1161/STROKEAHA.111.639575.

G

Gallagher, DA; Goetz, CG; Stebbins, G; Lees, AJ; Schrag, A; (2012) Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Mov Disord , 27 (1) 79 - 83. 10.1002/mds.23939.

Gallagher, DA; Lees, AJ; Schrag, A; Goetz, CG; Stebbins, G; (2012) Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Movement Disorders , 27 (1) 79 - 83. 10.1002/mds.23939.

Gandhi, S; Abramov, AY; (2012) Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev , 2012 428010 - ?. 10.1155/2012/428010. Gold open access

Gandhi, S; Vaarmann, A; Yao, Z; Duchen, MR; Wood, NW; Abramov, AY; (2012) Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease. PLoS One , 7 (5) , Article e37564 . 10.1371/journal.pone.0037564. Green and gold open access
file

Gardiner, A; Jaffer, F; Pittman, A; Gibbons, V; Wood, N; Hanna, M; Houlden, H; (2012) Next Generation Sequencing of Ion Channels in Neurological disorders. In: JOURNAL OF MEDICAL GENETICS. (pp. S119 - S119).

Gardiner, A; Kullmann, D; Wood, N; Ptacek, L; Houlden, H; Hanna, M; (2012) Episodic muscle and brain channels: Analysis of the PRRT2 gene and screening of a muscle channel panel. In: NEUROMUSCULAR DISORDERS. (pp. S17 - S17).

Gardiner, AR; Bhatia, KP; Stamelou, M; Dale, RC; Kurian, MA; Schneider, SA; ... Houlden, H; + view all (2012) PRRT2 gene mutations From paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. NEUROLOGY , 79 (21) 2115 - 2121.

Gardiner, AR; Bhatia, KP; Stamelou, M; Dale, RC; Kurian, MA; Schneider, SA; ... Houlden, H; + view all (2012) PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology , 79 (21) 2115 - 2121. 10.1212/WNL.0b013e3182752c5a.

Gaujoux-Viala, C; Knevel, R; Mandl, P; Nagy, G; Frank, M; Machado, P; ... EMEUNET working group,; + view all (2012) Who are the young professionals working in the field of rheumatology in Europe and what are their needs? An EMEUNET (EMerging EUlar NETwork) survey. Ann Rheum Dis , 71 (8) 1432 - 1433. 10.1136/annrheumdis-2011-201266.

Gegg, ME; Burke, D; Heales, SJ; Cooper, JM; Hardy, J; Wood, NW; Schapira, AH; (2012) Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann Neurol , 72 (3) 455 - 463. 10.1002/ana.23614.

Gerrish, A; Russo, G; Richards, A; Moskvina, V; Ivanov, D; Harold, D; ... Pankratz, VS; + view all (2012) The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. Journal of Alzheimer's Disease , 28 (2) 377 - 387. 10.3233/JAD-2011-110824.

Gerrish, A; Russo, G; Richards, A; Moskvina, V; Ivanov, D; Harold, D; ... Williams, J; + view all (2012) The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis , 28 (2) 377 - 387. 10.3233/JAD-2011-110824.

Gibbons, V; Labrum, RW; Haworth, A; Sweeney, MG; Wood, NW; Houlden, H; Hanna, MG; (2012) Episodic ataxia type 2-mutation analysis and screening recommendations. In: JOURNAL OF MEDICAL GENETICS. (pp. S87 - S87).

Gisslén, M; Fuchs, D; Hagberg, L; Svennerholm, B; Zetterberg, H; (2012) Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy. Scand J Infect Dis , 44 (12) 997 - 1000. 10.3109/00365548.2012.690526.

Giunti, P; Houlden, H; Gardner-Thorpe, C; Worth, PF; Johnson, J; Hilton, DA; ... Wood, NW; + view all (2012) Spinocerebellar ataxia type 11. In: UNSPECIFIED (521 - 534).

Giunti, P; Nethisinghe, S; Clayton, LM; Vermeer, S; Chapple, JP; Reilly, MM; Bremner, F; (2012) DETECTING RETINAL CHANGES IN AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY (ARSACS) USING OPTICAL COHERENCE TOMOGRAPHY (OCT). In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Glass, P; Lees, A; Bacellar, A; Zijlmans, J; Katzenschlager, R; Silveira-Moriyama, L; (2012) Clinical Features of Vascular Parkinsonism in Pathologically Confirmed Cases. In: NEUROLOGY.

Glass, PG; Lees, AJ; Bacellar, A; Zijlmans, J; Katzenschlager, R; Silveira-Moriyama, L; (2012) The clinical features of pathologically confirmed vascular parkinsonism. J Neurol Neurosurg Psychiatry , 83 (10) 1027 - 1029. 10.1136/jnnp-2012-302828.

Glass, PG; Lees, AJ; Silveira-Moriyama, L; Mathias, C; Mason, L; Best, C; ... Katzenschlager, R; + view all (2012) Olfaction in pathologically proven patients with multiple system atrophy. Movement Disorders , 27 (2) 327 - 328. 10.1002/mds.23972.

Glodzik, L; Mosconi, L; Tsui, W; de Santi, S; Zinkowski, R; Pirraglia, E; ... de Leon, MJ; + view all (2012) Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly. Neurobiol Aging , 33 (7) 1215 - 1227. 10.1016/j.neurobiolaging.2011.02.012.

Goate, A; Hardy, J; (2012) Twenty years of Alzheimer's disease-causing mutations. J Neurochem , 120 Suppl 1 3 - 8. 10.1111/j.1471-4159.2011.07575.x.

Gonzalez, C; Gomes, E; Kazachkova, N; Bettencourt, C; Raposo, M; Kay, TT; ... Vasconcelos, J; + view all (2012) Psychological well-being and family satisfaction levels five years after being confirmed as a carrier of the Machado-Joseph disease mutation. Genet Test Mol Biomarkers , 16 (12) 1363 - 1368. 10.1089/gtmb.2011.0370.

Graves, T; Cha, Y-H; Hahn, A; Barohn, R; Amato, A; Griggs, R; ... Hanna, M; + view all (2012) Episodic Ataxia Type 1: Characterization of the Disease and Its Effect on Quality of Life. In: NEUROLOGY.

Graves, T; Fialho, D; Smith, S; Cha, Y-H; Amato, A; Griggs, R; ... Hanna, M; + view all (2012) EEG Abnormalities in the Episodic Ataxias. In: NEUROLOGY.

Gray, A; Nirmalananthan, N; Malik, B; Dick, J; Hanna, M; Greensmith, L; (2012) Targeting the endogenous stress response in a mouse model of SBMA. In: NEUROMUSCULAR DISORDERS. (pp. S12 - S12).

Guerreiro, R; Kara, E; Le Ber, I; Bras, J; Rohrer, J; Taipa, R; ... Houlden, H; + view all (2012) Genetic analysis of inherited leukodystrophies: genotype phenotype correlations in the CSF1R gene. In: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. (pp. 9 - 9).

Guerreiro, RJ; Gustafson, DR; Hardy, J; (2012) The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiology of Disease , 33 (3) 437 - 456. 10.1016/j.neurobiolaging.2010.03.025. Green and gold open access
file

Guerreiro, RJ; Hardy, J; (2012) TOMM40 Association With Alzheimer Disease Tales of APOE and Linkage Disequilibrium. ARCHIVES OF NEUROLOGY , 69 (10) 1243 - 1244. 10.1001/archneurol.2012.1935.

Guerreiro, RJ; Hardy, J; (2012) TOMM40 association with Alzheimer disease: tales of APOE and linkage disequilibrium. Arch Neurol , 69 (10) 1243 - 1244. 10.1001/archneurol.2012.1935.

Guerreiro, RJ; Lohmann, E; Brás, JM; Gibbs, JR; Rohrer, JD; Gurunlian, N; ... Hardy, J; + view all (2012) Using Exome Sequencing to Reveal Mutations in TREM2 Presenting as a Frontotemporal Dementia-like Syndrome Without Bone Involvement. Arch Neurol 1 - 7. 10.1001/archneurol.2013.579.

Guerreiro, RJ; Lohmann, E; Kinsella, E; Brás, JM; Luu, N; Gurunlian, N; ... Singleton, A; + view all (2012) Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease. Neurobiol Aging , 33 (5) 1008.e17 - 1008.e23. 10.1016/j.neurobiolaging.2011.10.009.

Guix, FX; Wahle, T; Vennekens, K; Snellinx, A; Chávez-Gutiérrez, L; Ill-Raga, G; ... De Strooper, B; + view all (2012) Modification of γ-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease. EMBO Mol Med , 4 (7) 660 - 673. 10.1002/emmm.201200243.

Gupta, K; Patani, R; Baxter, P; Serio, A; Story, D; Tsujita, T; ... Chandran, S; + view all (2012) Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. Cell Death Differ , 19 (5) 779 - 787. 10.1038/cdd.2011.154.

Gustavsson, J; Mehlig, K; Leander, K; Strandhagen, E; Björck, L; Thelle, DS; ... Nyberg, F; + view all (2012) Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women. Atherosclerosis , 220 (2) 486 - 492. 10.1016/j.atherosclerosis.2011.10.011.

H

Haack, TB; Cuno, SM; Strom, TM; Meitinger, T; Prokisch, H; Wieland, T; ... Boddaert, N; + view all (2012) Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. American Journal of Human Genetics , 91 (6) 1144 - 1149. 10.1016/j.ajhg.2012.10.019.

Haack, TB; Hogarth, P; Kruer, MC; Gregory, A; Wieland, T; Schwarzmayr, T; ... Hayflick, SJ; + view all (2012) Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet , 91 (6) 1144 - 1149. 10.1016/j.ajhg.2012.10.019.

Hall, S; Öhrfelt, A; Constantinescu, R; Andreasson, U; Surova, Y; Bostrom, F; ... Hansson, O; + view all (2012) Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders. Arch Neurol , 69 (11) 1445 - 1452. 10.1001/archneurol.2012.1654.

Hansson, O; Stomrud, E; Vanmechelen, E; Östling, S; Gustafson, DR; Zetterberg, H; ... Skoog, I; + view all (2012) Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study. J Alzheimers Dis , 28 (1) 231 - 238. 10.3233/JAD-2011-111418.

Hardy, J; (2012) CSF biomarking for diagnosis and treatment assessment in neurodegeneration. JOURNAL OF NEUROCHEMISTRY , 123 (3) 339 - 341. 10.1111/j.1471-4159.2012.07928.x.

Hardy, J; (2012) Genetic analysis of disease in the era of whole genome analysis and public databases. Neurobiol Aging , 33 (4) 635 - ?. 10.1016/j.neurobiolaging.2011.12.039.

Hardy, J; Revesz, T; (2012) The spread of neurodegenerative disease. N Engl J Med , 366 (22) 2126 - 2128. 10.1056/NEJMcibr1202401.

Hölttä, M; Zetterberg, H; Mirgorodskaya, E; Mattsson, N; Blennow, K; Gobom, J; (2012) Peptidome analysis of cerebrospinal fluid by LC-MALDI MS. PLoS One , 7 (8) , Article e42555. 10.1371/journal.pone.0042555. Green and gold open access
file

Hernandez, DG; Nalls, MA; Moore, M; Chong, S; Dillman, A; Trabzuni, D; ... Cookson, MR; + view all (2012) Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain. Neurobiology of Disease , 47 (1) 20 - 28. 10.1016/j.nbd.2012.03.020. Green and gold open access
file

Hernandez, DG; Nalls, MA; Ylikotila, P; Keller, M; Hardy, JA; Majamaa, K; Singleton, AB; (2012) Genome Wide Assessment of Young Onset Parkinson's Disease from Finland. PLOS ONE , 7 (7) , Article e41859. 10.1371/journal.pone.0041859. Green and gold open access
file

Hersheson, J; Haworth, A; Houlden, H; (2012) The inherited ataxias: genetic heterogeneity, mutation databases, and future directions in research and clinical diagnostics. Hum Mutat , 33 (9) 1324 - 1332. 10.1002/humu.22132.

Hersheson, J; Hersheson, J; Pittman, A; Houlden, H; (2012) Developing a NGS screening panel for dominant cerebellar ataxia. In: JOURNAL OF MEDICAL GENETICS. (pp. S120 - S120).

Hersheson, J; Pittman, A; Houlden, H; (2012) Piloting targeted next-generation sequencing for screening the known ataxia genes: The next step for all diagnostic laboratories. In: MOVEMENT DISORDERS. (pp. S456 - S457).

Hersheson, JS; Mencacci, NE; Giunti, P; Wood, N; Houlden, H; (2012) Screening a UK cohort for spinocerebellar ataxia type 36 (SCA36). In: MOVEMENT DISORDERS. (pp. S183 - S183).

Heslegrave, AJ; Kapoor, RR; Eaton, S; Chadefaux, B; Akcay, T; Simsek, E; ... Hussain, K; + view all (2012) Leucine-sensitive hyperinsulinaemic hypoglycaemia in patients with loss of function mutations in 3-Hydroxyacyl-CoA Dehydrogenase. Orphanet J Rare Dis , 7 25 - ?. 10.1186/1750-1172-7-25. Gold open access

Hiscock, A; Dewar, L; Parton, M; Machado, P; Hanna, M; Ramdharry, G; (2012) Frequency and circumstances of falls in people with Inclusion Body Myositis. In: NEUROMUSCULAR DISORDERS. (pp. S30 - S31).

Hobart, JC; Cano, SJ; Warner, TT; Thompson, AJ; (2012) What sample sizes for reliability and validity studies in neurology? Journal of Neurology 1 - 14.

Hobart, JC; Cano, SJ; Warner, TT; Thompson, AJ; (2012) What sample sizes for reliability and validity studies in neurology? JOURNAL OF NEUROLOGY , 259 (12) 2681 - 2694. 10.1007/s00415-012-6570-y.

Holmstrom, KM; Baird, L; Dinkova-Kostova, AT; Abramov, AY; (2012) Nrf2 Controls Mitochondrial Bioenergetics. BIOPHYSICAL JOURNAL , 102 (3) 573A - 573A.

Horga, A; Rayan, DLR; Haworth, A; Matthews, E; Fialho, D; Sud, R; ... Hanna, MG; + view all (2012) Prevalence study of skeletal muscle channelopathies in England. In: NEUROMUSCULAR DISORDERS. (pp. S17 - S17).

Horga, A; Rayan, DLR; Matthews, E; Fialho, D; Sud, R; Haworth, A; ... Hanna, MG; + view all (2012) PREVALENCE STUDY OF SKELETAL MUSCLE CHANNELOPATHIES IN ENGLAND. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Houlden, H; (2012) A Commentary on 'Four novel C20ORF54 mutations identified in Brown-Vialetto-Van Laere syndrome patients.'. J Hum Genet , 57 (9) 555 - ?. 10.1038/jhg.2012.88.

Houlden, H; (2012) Extending the clinical spectrum of pain channelopathies. Brain , 135 (Pt 2) 313 - 316. 10.1093/brain/aws007.

Houlden, H; (2012) Sniffing out the cerebellum. J Neurol Neurosurg Psychiatry , 83 (10) 952 - 953. 10.1136/jnnp-2012-303136.

Houlden, H; Singleton, AB; (2012) The genetics and neuropathology of Parkinson's disease. Acta Neuropathol , 124 (3) 325 - 338. 10.1007/s00401-012-1013-5.

Huey, ED; Ferrari, R; Moreno, JH; Jensen, C; Morris, CM; Potocnik, F; ... Momeni, P; + view all (2012) FUS and TDP43 genetic variability in FTD and CBS. NEUROBIOLOGY OF AGING , 33 (5) , Article ARTN 1016.e9. 10.1016/j.neurobiolaging.2011.08.004.

I

Ince-Dunn, G; Okano, HJ; Jensen, KB; Park, WY; Zhong, R; Ule, J; ... Darnell, RB; + view all (2012) Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron , 75 (6) 1067 - 1080. 10.1016/j.neuron.2012.07.009.

International Stroke Genetics Consortium (ISGC),; Wellcome Trust Case Control Consortium 2 (WTCCC2),; Bellenguez, C; Bevan, S; Gschwendtner, A; Spencer, CC; ... Markus, HS; + view all (2012) Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet , 44 (3) 328 - 333. 10.1038/ng.1081.

J

Jacobi, H; Hauser, TK; Giunti, P; Globas, C; Bauer, P; Schmitz-Hübsch, T; ... Klockgether, T; + view all (2012) Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings. Cerebellum , 11 (1) 155 - 166. 10.1007/s12311-011-0292-z.

Jaffer, F; Graves, T; Gibbons, V; Gardiner, A; Hersheson, J; Hanna, M; Houlden, H; (2012) Episodic ataxia: screening candidate genes and genetic analysis of families. In: NEUROMUSCULAR DISORDERS. (pp. S17 - S17).

Jaffer, F; Murphy, SM; Scoto, M; Healy, E; Rossor, AM; Brandner, S; ... Reilly, MM; + view all (2012) BAG3 mutations: another cause of giant axonal neuropathy. J Peripher Nerv Syst , 17 (2) 210 - 216. 10.1111/j.1529-8027.2012.00409.x.

Jaffer, F; Murphy, SM; Scoto, M; Healy, E; Rossor A,; Brandner, S; ... Reilly, MM; + view all (2012) BAG3 Mutations: another cause of giant axonal neuropathy. Journal of the Peripheral Nervous System , 17 (2) 210 - 216.

Jaffer, F; Reilly, MM; Quinlivan, RR; Muntoni, F; Orrell, R; Wraige, E; ... Hanna, M; + view all (2012) AVOIDING UNPLANNED HOSPITAL ADMISSIONS IN PATIENTS WITH NEUROMUSCULAR DISEASES: A REGIONAL COLLABORATIVE AUDIT OF HOSPITAL ADMISSIONS. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Januário, F; Almeida, J; Serra, S; Amaral, C; Machado, P; Rodrigues, LA; (2012) [Characterization of patients with ankylosing spondylitis in hidrokinesitherapy - a multidimensional assessment]. Acta Med Port , 25 (5) 301 - 307.

Jebelli, JD; Dihanich, S; Civiero, L; Manzoni, C; Greggio, E; Lewis, PA; (2012) GTP binding and intramolecular regulation by the ROC domain of Death Associated Protein Kinase 1. Sci Rep , 2 695 - ?. 10.1038/srep00695. Gold open access

Johnson, JO; Gibbs, JR; Megarbane, A; Urtizberea, JA; Hernandez, DG; Foley, AR; ... Singleton, AB; + view all (2012) Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain , 135 (Pt 9) 2875 - 2882. 10.1093/brain/aws161.

Jonsson, M; Zetterberg, H; Rolstad, S; Edman, A; Gouw, AA; Bjerke, M; ... Wallin, A; + view all (2012) Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study. Dement Geriatr Cogn Disord , 34 (1) 61 - 67. 10.1159/000341576.

K

Kamynina, AV; Holmstrom, KM; Koroev, DO; Volpina, OM; Abramov, AY; (2012) Anti-peptide antibodies to synthetic fragments of alpha7-subunit acetylcholine receptor or prion protein protect cells against beta-amyloid toxicity. JOURNAL OF PEPTIDE SCIENCE , 18 S136 - S136.

Kara, E; Ling, H; Pittman, AM; Shaw, K; de Silva, R; Simone, R; ... Revesz, T; + view all (2012) The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features. Neurobioly of Aging , 33 (9) 2231.e7 - 2231.e14. 10.1016/j.neurobiolaging.2012.04.006. Green and gold open access
file

Kara, E; Xiromerisiou, G; Paudel, R; Revesz, T; Holton, J; Lees, A; ... Houlden, H; + view all (2012) Comprehensive genetic investigation of NBIA and complex dystonia-parkinsonism. In: MOVEMENT DISORDERS. (pp. S459 - S459).

König, J; McGlincy, NJ; Ule, J; (2012) Analysis of Protein-RNA Interactions with Single-Nucleotide Resolution Using iCLIP and Next-Generation Sequencing. Tag-Based Next Generation Sequencing 153 - 169. 10.1002/9783527644582.ch10.

Keenan, BT; Shulman, JM; Chibnik, LB; Raj, T; Tran, D; Sabuncu, MR; ... Neuroimaging, AD; + view all (2012) A coding variant in CR1 interacts with APOE-?4 to influence cognitive decline. HUMAN MOLECULAR GENETICS , 21 (10) 2377 - 2388. 10.1093/hmg/dds054.

Keller, MF; Saad, M; Bras, J; Bettella, F; Nicolaou, N; Simón-Sánchez, J; ... Wellcome Trust Case Control Consortium 2 (WTCCC2),; + view all (2012) Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. Hum Mol Genet , 21 (22) 4996 - 5009. 10.1093/hmg/dds335.

Kilarski, LL; Pearson, JP; Newsway, V; Majounie, E; Knipe, MD; Misbahuddin, A; ... Morris, HR; + view all (2012) Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. Mov Disord , 27 (12) 1522 - 1529. 10.1002/mds.25132.

Kinghorn, KJ; Kaliakatsos, M; Blakely, EL; Taylor, RW; Rich, P; Clarke, A; Omer, S; (2012) Hypertrophic olivary degeneration on magnetic resonance imaging in mitochondrial syndromes associated with POLG and SURF1 mutations. Journal of Neurology 1 - 7.

Klöhn, PC; Farmer, M; Linehan, JM; O'Malley, C; Fernandez de Marco, M; Taylor, W; ... Collinge, J; + view all (2012) PrP antibodies do not trigger mouse hippocampal neuron apoptosis. Science , 335 (6064) 52 - ?. 10.1126/science.1215579.

Kojovic, M; Sheerin, U; Rubio-Agusti, I; Bras, J; Wood, N; Houlden, H; ... Bhatia, K; + view all (2012) Young Onset Parkinson's Disease Due to Homozygous Duplication of SNCA in a Consanguineous Family from Pakistan. In: NEUROLOGY.

Kojovic, M; Sheerin, UM; Rubio-Agusti, I; Saha, A; Bras, J; Gibbons, V; ... Bhatia, KP; + view all (2012) Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family. Mov Disord , 27 (14) pp. 1829-1830. 10.1002/mds.25199. Green and gold open access
file

Kojovic, M; Sheerin, UM; Rubio-Agusti, I; Saha, A; Bras, J; Gibbons, V; ... Bhatia, KP; + view all (2012) Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family. Movement disorders : official journal of the Movement Disorder Society , 27 (14) 1827 - 1829. 10.1002/mds.25114.

Korkodilos, M; Hajioff, S; Gardner, C; Overett, S; Ibrahim, S; Jaffer, F; Hanna, MG; (2012) Audit of unplanned admissions in neuromuscular patients: a collaborative audit. Audit, Information and Analysis Unit / London Specialised Commissioning Group / MRC Centre for Neuromuscular Diseases: United Kingdom. Green open access
file

Kosicek, M; Zetterberg, H; Andreasen, N; Peter-Katalinic, J; Hecimovic, S; (2012) Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease. Neurosci Lett , 516 (2) 302 - 305. 10.1016/j.neulet.2012.04.019.

Koutsis, G; Karadima, G; Pandraud, A; Sweeney, MG; Paudel, R; Houlden, H; ... Panas, M; + view all (2012) Genetic screening of Greek patients with Huntington’s disease phenocopies identifies an SCA8 expansion. J Neurol , 259 (9) 1874 - 1878. 10.1007/s00415-012-6430-9.

Koutsis, G; Mok, K; Schottlaender, L; Polke, J; Panas, M; Houlden, H; (2012) High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 726 - 726).

Koutsis, G; Pandraud, A; Polke, JM; Wood, NW; Panas, M; Karadima, G; Houlden, H; (2012) Novel peripheral myelin protein 22 (PMP22) micromutations associated with variable phenotypes in Greek patients with Charcot-Marie-Tooth disease. Brain , 135 (Pt 8) e217 - 6. 10.1093/brain/aws034.

Koutsis, G; Pemble, S; Sweeney, MG; Paudel, R; Wood, NW; Panas, M; ... Houlden, H; + view all (2012) Analysis of spinocerebellar ataxias due to expanded triplet repeats in Greek patients with cerebellar ataxia. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 731 - 731).

Koutsis, G; Pemble, S; Sweeney, MG; Paudel, R; Wood, NW; Panas, M; ... Houlden, H; + view all (2012) Analysis of spinocerebellar ataxias due to expanded triplet repeats in Greek patients with cerebellar ataxia. J Neurol Sci , 318 (1-2) 178 - 180. 10.1016/j.jns.2012.03.019.

Kovac, S; Domijan, AM; Walker, MC; Abramov, AY; (2012) Prolonged seizure activity impairs mitochondrial bioenergetics and induces cell death. J Cell Sci , 125 (Pt 7) 1796 - 1806. 10.1242/jcs.099176.

Kruczyk, M; Zetterberg, H; Hansson, O; Rolstad, S; Minthon, L; Wallin, A; ... Andersson, MG; + view all (2012) Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment. J Neural Transm , 119 (7) 821 - 831. 10.1007/s00702-012-0812-0.

Kruer, M; Jepperson, T; Steiner, R; Russman, B; Blasco, P; Fan, G; ... Houlden, H; + view all (2012) Mutations in ADD3 Lead to Inherited Forms of Spastic Diplegia and Spastic Quadriplegia. In: ANNALS OF NEUROLOGY. (pp. S218 - S218).

Kruer, MC; Boddaert, N; Schneider, SA; Houlden, H; Bhatia, KP; Gregory, A; ... Hayflick, SJ; + view all (2012) Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol , 33 (3) 407 - 414. 10.3174/ajnr.A2677.

Kruer, MC; Hayflick, SJ; Paudel, R; Kara, E; Foltynie, T; Lees, A; ... Gregory, A; + view all (2012) Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. Neuroscience Letters , 523 (1) 35 - 38. 10.1016/j.neulet.2012.06.036.

Kruer, MC; Paudel, R; Wagoner, W; Sanford, L; Kara, E; Gregory, A; ... Houlden, H; + view all (2012) Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. Neurosci Lett , 523 (1) 35 - 38. 10.1016/j.neulet.2012.06.036.

Krut, JJ; Zetterberg, H; Blennow, K; Cinque, P; Hagberg, L; Price, RW; ... Gisslén, M; + view all (2012) Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. Journal of Neurology 1 - 7.

L

Lace, G; Ince, PG; Brayne, C; Savva, GM; Matthews, FE; de Silva, R; ... MRC-CFAS,; + view all (2012) Mesial Temporal Astrocyte Tau Pathology in the MRC-CFAS Ageing Brain Cohort. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS , 34 (1) 15 - 24. 10.1159/000341581.

Laires, PA; Canhão, H; Araújo, D; Fonseca, JE; Machado, P; Mourão, AF; ... Branco, JC; + view all (2012) CoReumaPt protocol: the Portuguese cohort of rheumatic diseases. Acta Reumatol Port , 37 (1) 18 - 24.

Landgren, S; von Otter, M; Palmér, MS; Zetterström, C; Nilsson, S; Skoog, I; ... Kettunen, P; + view all (2012) A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease. J Neural Transm , 119 (7) 833 - 842. 10.1007/s00702-012-0823-x.

Laura, M; Murphy, SM; Hornemann, T; Bode, H; Polke, J; Blake, J; ... Reilly, MM; + view all (2012) Hereditary sensory neuropathy type 1: correlation of severity and plasma atypical deoxy-sphyngoid bases. In: NEUROMUSCULAR DISORDERS. (pp. S18 - S18).

Lee, H-Y; Huang, Y; Bruneau, N; Roll, P; Roberson, EDO; Hermann, M; ... Ptacek, LJ; + view all (2012) Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions. CELL REPORTS , 1 (1) 2 - 12. 10.1016/j.celrep.2011.11.001. Gold open access

Lee, H-Y; Huang, Y; Bruneau, N; Roll, P; Roberson, EDO; Hermann, M; ... Ptacek, LJ; + view all (2012) Mutations in the Novel Protein PRRT2 Cause Infantile Convulsions with Paroxysmal Kinesigenic Dyskinesia. In: ANNALS OF NEUROLOGY. (pp. S59 - S59).

Lee, HY; Huang, Y; Bruneau, N; Roll, P; Roberson, ED; Hermann, M; ... Ptáček, LJ; + view all (2012) Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep , 1 (1) 2 - 12. 10.1016/j.celrep.2011.11.001.

Lee, HY; Huang, Y; Bruneau, N; Roll, P; Roberson, ED; Hermann, M; ... Ptáček, LJ; + view all (2012) Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. In: Cell Rep. (pp. 2 - 12).

Lees, A; (2012) East meets west to provide the best for PD patients. Focus on Parkinson's Disease , 23 (1) 2 - 2.

Lees, A; (2012) Two decades of evolving care with pump therapies - What have we learned? European Neurological Review , 7 (SUPPL.1) 5 - 7.

Lees, A; Costa, R; Oliveira, C; Lopes, N; Nunes, T; Soares-da-Silva, P; (2012) Design of a double-blind, placebo-controlled, phase-III trial in patients with Parkinson's disease and end-of-dose motor fluctuations: opicapone superiority vs. placebo. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 695 - 695).

Lees, A; Costa, R; Oliveira, C; Lopes, N; Nunes, T; Soares-da-Silva, P; (2012) The design of a double-blind, placebo-controlled, multi-national phase-III trial in patients with Parkinson's disease and end-of-dose motor fluctuations: Opicapone superiority vs. placebo. In: MOVEMENT DISORDERS. (pp. S127 - S127).

Lees, A; Fahn, S; Eggert, KM; Jankovic, J; Lang, A; Micheli, F; ... Kumar, D; + view all (2012) Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. MOVEMENT DISORDERS , 27 (2) 284 - 300. 10.1002/mds.23983.

Lees, A; Fahn, S; Eggert, KM; Oertel, WH; Jankovic, J; Lang, A; ... Kumar, D; + view all (2012) Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. Movement Disorders , 27 (2) 284 - 288. 10.1002/mds.23983.

Lees, AJ; (2012) A MODERN PERSPECTIVE ON THE TOP 100 CITED JNNP PAPERS OF ALL TIME The relevance of the Lewy Body to the pathogenesis of idiopathic Parkinson's disease Accuracy of clinical diagnosis of idiopathic Parkinson's disease. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (10) 954 - 955. 10.1136/jnnp-2012-302969.

Lees, AJ; (2012) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry , 83 (10) 954 - 955. 10.1136/jnnp-2012-302969.

Lees, AJ; Woodward, RMP; Scott, AEM; Eadie, MJ; (2012) W R Gowers 1895: two unpublished post-graduate lectures. BRAIN , 135 3165 - 3177. 10.1093/brain/aws029.

Lescai, F; Bonfiglio, S; Bacchelli, C; Chanudet, E; Waters, A; Sisodiya, SM; ... Stupka, E; + view all (2012) Characterisation and validation of insertions and deletions in 173 patient exomes. PLoS One , 7 (12) , Article e51292 . 10.1371/journal.pone.0051292. Green and gold open access
file

Lill, CM; Roehr, JT; McQueen, MB; Kavvoura, FK; Bagade, S; Schjeide, B-MM; ... WTCCC2,; + view all (2012) Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database. PLOS GENETICS , 8 (3) , Article e1002548. 10.1371/journal.pgen.1002548. Green and gold open access
file

Lima, M; Bruges-Armas, J; Bettencourt, C; (2012) Non-Mendelian Genetic Aspects in Spinocerebellar Ataxias (SCAS): The Case of Machado-Joseph Disease (MJD). In: Spinocerebellar Ataxia. (27 - 40). InTech: Rijeka.

Lin, MT; Beal, MF; Cantuti-Castelvetri, I; Lees, AJ; Simon, DK; (2012) Reply. Annals of Neurology , 72 (5) 823 - 824. 10.1002/ana.23739.

Lin, MT; Cantuti-Castelvetri, I; Lees, AJ; Beal, MF; Simon, DK; (2012) Somatic Mitochondrial DNA Mutations and Parkinsonism Reply. ANNALS OF NEUROLOGY , 72 (5) 823 - 824. 10.1002/ana.23739.

Lin, MT; Cantuti-Castelvetri, I; Zheng, K; Jackson, KE; Tan, YB; Arzberger, T; ... Simon, DK; + view all (2012) Somatic mitochondrial DNA mutations in early parkinson and incidental lewy body disease. ANNALS OF NEUROLOGY , 71 (6) 850 - 854. 10.1002/ana.23568.

Ling, H; de Silva, R; Courtney, R; Massey, L; Bajaj, N; Lowe, J; ... Revesz, T; + view all (2012) Clinicopathological study of progressive supranuclear palsy presenting with corticobasal syndrome. In: MOVEMENT DISORDERS. (pp. S384 - S384).

Ling, H; de Silva, R; Massey, L; Bajaj, N; Lowe, J; Holton, J; ... Revesz, T; + view all (2012) Clinicopathological correlation of progressive supranuclear palsy presenting with corticobasal syndrome. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 290 - 290).

Ling, H; Massey, L; Lees, A; Brown, P; Day, B; (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. MOVEMENT DISORDERS , 27 S384 - S385.

Ling, H; Massey, LA; Lees, AJ; Brown, P; Day, BL; (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. Brain , 135 (Pt 4) 1141 - 1153. 10.1093/brain/aws038.

Ling, H; Massey, LA; Lees, AJ; Brown, P; Day, BL; (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. Brain , 135 (Pt 4) 1141 - 1153. 10.1093/brain/aws038.

Ling, H; Petrovic, I; Day, BL; Lees, AJ; (2012) Smoking-induced transient motor deterioration in a levodopa-treated patient with Parkinson's disease. J Neurol , 259 (11) 2419 - 2423. 10.1007/s00415-012-6515-5.

Ling, H; Petrovic, I; Lees, AJ; Day, BL; (2012) Smoking-induced transient motor deterioration in a levodopa-treated patient with Parkinson's disease. Journal of Neurology , 259 (11) 2419 - 2423. 10.1007/s00415-012-6515-5.

Liu, Y-T; Laura, M; Wood, N; Reilly, MM; Houlden, H; (2012) Mutations of the kinesin family member 5A (KIF5A) gene in patients with pure or complex Charcot-Marie-Tooth type 2 (CMT2). In: NEUROMUSCULAR DISORDERS. (pp. S18 - S18).

Liu, Y-T; Pittman, A; Hughes, D; Polke, JM; Sweeney, MG; Houlden, H; Reilly, MM; (2012) Application of targeted resequencing panels in genetic diagnosis of Charcot-Marie-Tooth disease. In: JOURNAL OF MEDICAL GENETICS. (pp. S119 - S119).

Lo, C; Shorvon, S; Davis, M; Houlden, H; Gibbons, V; Wood, N; (2012) Genetic linkage analysis of a large family with photoparoxysmal response. Epilepsy Res , 99 (1-2) 38 - 45. 10.1016/j.eplepsyres.2011.10.013.

Loane, C; Politis, M; Wu, K; O'Sullivan, SS; Woodhead, Z; Lawrence, AD; ... Piccini, P; + view all (2012) Drug-cue elicited frontal and limbic dysfunction in Parkinson's disease patients with dopamine dysregulation syndrome. In: MOVEMENT DISORDERS. (pp. S245 - S245).

Lohmann, E; Guerreiro, RJ; Erginel-Unaltuna, N; Gurunlian, N; Bilgic, B; Gurvit, H; ... Singleton, A; + view all (2012) Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients. Neurobiol Aging , 33 (8) 1850.e17 - 1850.e27. 10.1016/j.neurobiolaging.2012.02.020.

Lubbe, SJ; Pittman, AM; Olver, B; Lloyd, A; Vijayakrishnan, J; Dobbins, S; ... Gómez-Skarmeta, JL; + view all (2012) The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4. Oncogene , 31 (33) 3777 - 3784. 10.1038/onc.2011.564.

Lubbe, SJ; Pittman, AM; Olver, B; Lloyd, A; Vijayakrishnan, J; Naranjo, S; ... Houlston, RS; + view all (2012) The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4. Oncogene , 31 (33) 3777 - 3784. 10.1038/onc.2011.564.

Luk, C; Compta, Y; Magdalinou, N; Marti, MJ; Hondhamuni, G; Zetterberg, H; ... de Silva, R; + view all (2012) Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. Journal of Neurochemistry 10.1111/j.1471-4159.2012.07911.x.

M

Maccecchini, ML; Chang, MY; Pan, C; John, V; Zetterberg, H; Greig, NH; (2012) Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans. J Neurol Neurosurg Psychiatry , 83 (9) 894 - 902. 10.1136/jnnp-2012-302589.

Machado, P; Bernardo, A; Cravo, AR; Rodrigues, A; Malcata, A; Nour, D; ... Portuguese Society of Rheumatology,; + view all (2012) Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 update. Acta Reumatol Port , 37 (1) 40 - 47.

Machado, P; Bogas, M; Ribeiro, A; Costa, J; Neto, A; Sepriano, A; ... Portuguese Society of Rheumatology,; + view all (2012) 2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis. Acta Reumatol Port , 37 (1) 26 - 39.

Machado, P; Cortese, A; Morrow, J; Dewar, L; Hiscock, A; Miller, A; ... Hanna, MG; + view all (2012) The Natural History of Sporadic Inclusion Body Myositis-an Observational Longitudinal Study. In: ARTHRITIS AND RHEUMATISM. (pp. S99 - S100).

Machado, P; Hudson, J; Miller, A; Morrow, J; Parton, M; Bushby, K; Hanna, M; (2012) VALOSIN CONTAINING PROTEIN (VCP) AND MYOFIBRILLAR MYOPATHIES (MFM) GENES' MUTATIONS ARE NOT ASSOCIATED WITH SPORADIC INCLUSION BODY MYOSITIS (sIBM). In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Machado, P; Hudson, J; Miller, A; Morrow, J; Parton, M; Bushby, K; Hanna, MG; (2012) Myofibrillar myopathies (MFM), valosin containing protein (VCP) and glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) genes' mutations are not associated with sporadic inclusion body myositis (sIBM). In: NEUROMUSCULAR DISORDERS. (pp. S30 - S30).

Machado, P; Landewé, RB; Braun, J; Baraliakos, X; Hermann, KG; Hsu, B; ... van der Heijde, D; + view all (2012) MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor. Ann Rheum Dis , 71 (12) 2002 - 2005. 10.1136/annrheumdis-2012-201999.

Machado, P; Santos, MJ; Fonseca, JE; (2012) [Recommendations of the Portuguese Society of Rheumatology: a contribution towards improving the quality of health care]. Acta Reumatol Port , 37 (1) 7 - 8.

Magdalinou, NK; Luk, C; Compta, Y; Marti, MJ; Lees, AJ; de Silva, R; (2012) Novel method for quantification of 3R-and 4R-tau isoforms in the cerebrospinal fluid of patients with atypical parkinsonian syndromes. In: MOVEMENT DISORDERS. (pp. S385 - S386).

Mahoney, CJ; Beck, J; Rohrer, JD; Lashley, T; Mok, K; Shakespeare, T; ... Warren, JD; + view all (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain , 135 (3) 736 - 750. 10.1093/brain/awr361. Green and gold open access
file

Majounie, E; Abramzon, Y; Renton, AE; Perry, R; Bassett, SS; Pletnikova, O; ... Traynor, BJ; + view all (2012) Repeat Expansion in C9ORF72 in Alzheimer's Disease. NEW ENGLAND JOURNAL OF MEDICINE , 366 (3) 283 - 284. 10.1056/NEJMc1113592.

Majounie, E; Renton, AE; Mok, K; Dopper, EG; Waite, A; Rollinson, S; ... Traynor, BJ; + view all (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurology , 11 (4) 323 - 330. 10.1016/S1474-4422(12)70043-1. Green and gold open access
file

Mandemakers, W; Snellinx, A; O'Neill, MJ; de Strooper, B; (2012) LRRK2 expression is enriched in the striosomal compartment of mouse striatum. Neurobiol Dis , 48 (3) 582 - 593. 10.1016/j.nbd.2012.07.017.

Martins, S; Soong, BW; Wong, VC; Giunti, P; Stevanin, G; Ranum, LP; ... Nicholson, GA; + view all (2012) Mutational origin of Machado-Joseph disease in the Australian Aboriginal communities of Groote Eylandt and Yirrkala. Arch Neurol , 69 (6) 746 - 751. 10.1001/archneurol.2011.2504.

Massey, LA; Micallef, C; Paviour, DC; O'Sullivan, SS; Ling, H; Williams, DR; ... Jäger, HR; + view all (2012) Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Movement Disorders , 27 (14) 1754 - 1762. 10.1002/mds.24968.

Massey, LA; Miranda, MA; Zrinzo, L; Al-Helli, O; Parkes, HG; Thornton, JS; ... Yousry, TA; + view all (2012) High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validation. Neuroimage , 59 (3) 2035 - 2044. 10.1016/j.neuroimage.2011.10.016.

Matilde, L; Eichler, F; Hornemann, T; Murphy, SM; Polke, J; Bull, K; ... Reilly, MM; + view all (2012) HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 1: CORRELATION OF SEVERITY AND PLASMA ATYPICAL DEOXY-SPHYNGOID BASES. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Matsuki, T; Zaka, M; Guerreiro, R; van der Brug, MP; Cooper, JA; Cookson, MR; ... Howell, BW; + view all (2012) Identification of Stk25 as a genetic modifier of Tau phosphorylation in Dab1-mutant mice. PLoS One , 7 (2) , Article e31152 . 10.1371/journal.pone.0031152. Green and gold open access
file

Matta, S; Van Kolen, K; da Cunha, R; van den Bogaart, G; Mandemakers, W; Miskiewicz, K; ... Verstreken, P; + view all (2012) LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. Neuron , 75 (6) 1008 - 1021. 10.1016/j.neuron.2012.08.022.

Matthews, E; Plotz, PH; Portaro, S; Parton, M; Elliott, P; Humbel, RL; ... Hanna, MG; + view all (2012) A case of necrotizing myopathy with proximal weakness and cardiomyopathy. Neurology , 78 (19) 1527 - 1532. 10.1212/WNL.0b013e3182553baa.

Mattsson, N; Andreasson, U; Carrillo, MC; Persson, S; Shaw, LM; Zegers, I; ... Blennow, K; + view all (2012) Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers. Biomark Med , 6 (4) 401 - 407. 10.2217/bmm.12.41.

Mattsson, N; Olsson, M; Gustavsson, MK; Kosicek, M; Malnar, M; Månsson, JE; ... Portelius, E; + view all (2012) Amyloid-β metabolism in Niemann-Pick C disease models and patients. Metab Brain Dis , 27 (4) 573 - 585. 10.1007/s11011-012-9332-8.

Mattsson, N; Portelius, E; Rolstad, S; Gustavsson, M; Andreasson, U; Stridsberg, M; ... Zetterberg, H; + view all (2012) Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment. J Alzheimers Dis , 30 (4) 767 - 778. 10.3233/JAD-2012-120019.

Mattsson, N; Rajendran, L; Zetterberg, H; Gustavsson, M; Andreasson, U; Olsson, M; ... Portelius, E; + view all (2012) BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system. PLoS One , 7 (2) , Article e31084. 10.1371/journal.pone.0031084. Green and gold open access
file

Mattsson, N; Rosén, E; Hansson, O; Andreasen, N; Parnetti, L; Jonsson, M; ... Zetterberg, H; + view all (2012) Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology , 78 (7) 468 - 476. 10.1212/WNL.0b013e3182477eed.

Mattsson, N; Zegers, I; Andreasson, U; Bjerke, M; Blankenstein, MA; Bowser, R; ... Portelius, E; + view all (2012) Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42. Biomark Med , 6 (4) 409 - 417. 10.2217/bmm.12.39.

Mattsson, N; Zetterberg, H; (2012) What is a certified reference material? Biomark Med , 6 (4) 369 - 370. 10.2217/bmm.12.37.

Mattsson, N; Zetterberg, H; Bianconi, S; Yanjanin, NM; Fu, R; Månsson, JE; ... Blennow, K; + view all (2012) Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C. JIMD Rep , 3 45 - 52. 10.1007/8904_2011_47.

McGlincy, NJ; Valomon, A; Chesham, JE; Maywood, ES; Hastings, MH; Ule, J; (2012) Regulation of alternative splicing by the circadian clock and food related cues. Genome Biol , 13 (6) R54 - ?. 10.1186/gb-2012-13-6-r54.

McNaughton, D; Knight, W; Guerreiro, R; Ryan, N; Lowe, J; Poulter, M; ... Mead, S; + view all (2012) Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobioly of Aging , 33 (2) 426.e13 - 426.e21. 10.1016/j.neurobiolaging.2010.10.010. Green and gold open access
file

McNeill, A; Duran, R; Proukakis, C; Bras, J; Hughes, D; Mehta, A; ... Schapira, AH; + view all (2012) Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Mov Disord , 27 (4) 526 - 532. 10.1002/mds.24945.

Mead, S; Beck, J; Poulter, M; Rohrer, J; Adamson, G; Hensman, D; ... Collinge, J; + view all (2012) Large C9ORF72 hexanucleotide expansions arise spontaneously in the healthy population but can be distinguished from pathogenic mutations by Sothern Blotting. In: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. (pp. 285 - 286).

Mencacci, NE; Labrum, R; Haworth, A; Sweeney, M; Pittman, A; Stamelou, M; ... Hardy, J; + view all (2012) Is anything lying behind parkin heterozygous mutations? In: MOVEMENT DISORDERS. (pp. S462 - S463).

Michaki, V; Guix, FX; Vennekens, K; Munck, S; Dingwall, C; Davis, JB; ... Wahle, T; + view all (2012) Down-regulation of the ATP-binding cassette transporter 2 (Abca2) reduces amyloid-β production by altering Nicastrin maturation and intracellular localization. J Biol Chem , 287 (2) 1100 - 1111. 10.1074/jbc.M111.288258.

Miller, A; Ahmed, M; Hanna, MG; Greensmith, L; (2012) DEVELOPING NEW THERAPEUTIC STRATEGIES FOR INCLUSION BODY MYOSITIS. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Mittag, F; Büchel, F; Jahn, A; Zell, A; Saad, M; Martinez, M; ... Brice, A; + view all (2012) Use of support vector machines for disease risk prediction in genome-wide association studies: Concerns and opportunities. Human Mutation , 33 (12) 1708 - 1718. 10.1002/humu.22161.

Mittag, F; Büchel, F; Saad, M; Jahn, A; Schulte, C; Bochdanovits, Z; ... International Parkinson’s Disease Genomics Consortium,; + view all (2012) Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunities. Hum Mutat , 33 (12) 1708 - 1718. 10.1002/humu.22161.

Mok, K; Traynor, BJ; Schymick, J; Tienari, PJ; Laaksovirta, H; Peuralinna, T; ... Hardy, J; + view all (2012) Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiology of Disease , 33 (1) 209.e3 - 209.e8. 10.1016/j.neurobiolaging.2011.08.005. Green and gold open access
file

Mok, KY; Koutsis, G; Schottlaender, LV; Polke, J; Panas, M; Houlden, H; (2012) High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients. Neurobioly of Aging , 33 (8) 1851.e1 - 1851.e5. 10.1016/j.neurobiolaging.2012.02.021. Green and gold open access
file

Morales-Briceño, H; Rodríguez-Violante, M; Cervantes-Arriaga, A; Irani, SR; Lees, AJ; Silveira-Moriyama, L; (2012) Opsoclonus myoclonus syndrome associated with GQ1b antibodies. Mov Disord , 27 (13) 1615 - 1616. 10.1002/mds.25169.

Morrow, J; Sinclair, CDJ; Fischmann, A; Thornton, JS; Yousry, TA; Reilly, MM; Hanna, MG; (2012) MRI QUANTIFICATION OF LOWER LIMB MUSCLE FATTY ATROPHY: A POTENTIAL OUTCOME MEASURE IN CHRONIC NEUROMUSCULAR DISEASES. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Morrow, JM; Sinclair, CDJ; Fischmann, A; Thornton, JS; Reilly, MM; Hanna, MG; Yousry, TA; (2012) MRI quantification of abnormal muscle water distribution in chronic neuromuscular diseases: a sensitive biomarker. In: NEUROMUSCULAR DISORDERS. (pp. S33 - S33).

Moscovich, M; Munhoz, R; Teive, H; Raskin, S; Liu, J; McFarland, K; ... Silveira-Moriyama, L; + view all (2012) To Investigate Olfactory Impairment in Cerebellar Ataxia. In: NEUROLOGY.

Moscovich, M; Munhoz, RP; Teive, HA; Liu, J; McFarland, K; Ashizawa, T; ... Silveira-Moriyama, L; + view all (2012) Olfactory impairment in familial ataxias. Journal of Neurology, Neurosurgery and Psychiatry , 83 (10) 970 - 974. 10.1136/jnnp-2012-302770.

Moscovich, M; Munhoz, RP; Teive, HA; Raskin, S; Carvalho, MDEJ; Barbosa, ER; ... Silveira-Moriyama, L; + view all (2012) Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry , 83 (10) 970 - 974. 10.1136/jnnp-2012-302770.

Movérare-Skrtic, S; Johansson, P; Mattsson, N; Hansson, O; Wallin, A; Johansson, JO; ... Svensson, J; + view all (2012) Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study. Exp Gerontol , 47 (2) 179 - 182. 10.1016/j.exger.2011.12.005.

Murphy, S; Pandraud, A; Liu, Y; Fawcett, K; Polke, JM; Davidson, G; ... Reilly, MM; + view all (2012) CHARCOT-MARIE-TOOTH DISEASE: GENETIC DIAGNOSES IN A SPECIALIST CLINIC. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Murphy, SM; Davidson, GL; Brandner, S; Houlden, H; Reilly, MM; (2012) Mutation in FAM134B causing severe hereditary sensory neuropathy. J Neurol Neurosurg Psychiatry , 83 (1) 119 - 120. 10.1136/jnnp.2010.228965.

Murphy, SM; Davidson, GL; Houlden, H; Reilly, MM; Brandner, S; (2012) Mutation in FAM134B causing severe hereditary sensory neuropathy. Journal of Neurology, Neurosurgery and Psychiatry , 83 (1) 119 - 120. 10.1136/jnnp.2010.228965.

Murphy, SM; Laura, M; Ernst, D; Liu, Y-T; Blake, J; Donaghy, M; ... Reilly, MM; + view all (2012) Clinical and genetic characterisation of hereditary sensory neuropathy type 1 caused by mutations in SPTLC2. In: NEUROMUSCULAR DISORDERS. (pp. S19 - S19).

Murphy, SM; Laura, M; Fawcett, K; Pandraud, A; Liu, YT; Davidson, GL; ... Reilly, MM; + view all (2012) Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry , 83 (7) 706 - 710. 10.1136/jnnp-2012-302451.

Murphy, SM; Laura, M; Pandraud, A; Liu, Y-T; Davidson, GL; Rossor, AM; ... Polke, JM; + view all (2012) Charcot-Marie-Tooth disease: Frequency of genetic subtypes and guidelines for genetic testing. Journal of Neurology, Neurosurgery and Psychiatry , 83 (7) 706 - 710. 10.1136/jnnp-2012-302451.

Murphy, SM; Ovens, R; Polke, J; Siskind, CE; Laurà, M; Bull, K; ... Reilly, MM; + view all (2012) X inactivation in females with X-linked Charcot-Marie-Tooth disease. Neuromuscular Disorders , 22 (7) 617 - 621. 10.1016/j.nmd.2012.02.009. Green and gold open access
file

N

Nesbitt, V; Pitceathly, R; Cockell, S; Poulton, J; Rahman, S; Hanna, M; ... McFarland, R; + view all (2012) The medical research council neuromuscular centre for translational research mitochondrial disease patient cohort study UK: from conceptualisation to utilisation. In: NEUROMUSCULAR DISORDERS. (pp. S24 - S24).

Neselius, S; Brisby, H; Theodorsson, A; Blennow, K; Zetterberg, H; Marcusson, J; (2012) CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma. PLoS One , 7 (4) , Article e33606. 10.1371/journal.pone.0033606. Green and gold open access
file

Nesic, I; Guix, FX; Vennekens, K; Michaki, V; Van Veldhoven, PP; Feiguin, F; ... Wahle, T; + view all (2012) Alterations in phosphatidylethanolamine levels affect the generation of Aβ. Aging Cell , 11 (1) 63 - 72. 10.1111/j.1474-9726.2011.00760.x.

Nethisinghe, S; Menon, RP; Faggiano, S; Vannocci, T; Rezaei, H; Pemble, S; ... Giunti, P; + view all (2012) The role of interruptions in the polyglutamine tract of ATXN1 in SCA1 pathology. In: JOURNAL OF MEDICAL GENETICS. (pp. S91 - S91).

Noyce, A; Bestwick, J; Hawkes, CH; Knowles, CH; Hardy, J; Lees, AJ; ... Schrag, A; + view all (2012) AN ALGORITHM TO IDENTIFY INDIVIDUALS AT HIGH-RISK OF PARKINSON'S DISEASE IN THE COMMUNITY. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Noyce, A; Silveira-Moriyama, L; Lees, AJ; Schrag, A; Bestwick, J; Hawkes, CH; ... Knowles, CH; + view all (2012) A PILOT STUDY OF AN ALGORITHM DESIGNED TO IDENTIFY PARKINSON'S DISEASE IN THE EARLY, NON-MOTOR PHASE. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Noyce, A; Treacy, C; Budu, C; Fearnley, J; Lees, AJ; Giovannoni, G; (2012) THE NEW BRADYKINESIA AKINESIA INCOORDINATION (BRAIN) TEST: AN ONLINE TEST OF UPPER LIMB MOVEMENT. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Noyce, AJ; Bestwick, J; Silveira-Moriyama, L; Hawkes, CH; Giovannoni, G; Lees, AJ; Schrag, A; (2012) Risk factors and early non-motor features for Parkinson's disease: A systematic review and meta-analysis. In: MOVEMENT DISORDERS. (pp. S4 - S4).

Noyce, AJ; Bestwick, JP; Silveira-Moriyama, L; Hawkes, CH; Giovannoni, G; Lees, AJ; Schrag, A; (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol , 72 (6) 893 - 901. 10.1002/ana.23687.

Noyce, AJ; Silveira-Moriyama, L; Gilpin, P; Ling, H; Howard, R; Lees, AJ; (2012) Severe dysphagia as a presentation of Parkinson's disease. Mov Disord , 27 (3) 457 - 458. 10.1002/mds.24006.

Noyce, AJ; Silveira-Moriyama, L; Lees, AJ; Schrag, A; Hawkes, CH; Giovannoni, G; Bestwick, JP; (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Annals of Neurology , 72 (6) 893 - 901. 10.1002/ana.23687.

Noyce, AJ; Treacy, C; Budu, C; Fearnley, J; Lees, AJ; Giovannoni, G; (2012) The new Bradykinesia Akinesia Incoordination (BRAIN) test: preliminary data from an online test of upper limb movement. Mov Disord , 27 (1) 157 - 158. 10.1002/mds.23947.

O

O'Sullivan, SS; Cheshire, P; Djamshidian, A; Bertram, K; Williams, DR; Lees, AJ; Foltynie, T; (2012) Is the brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism associated with impulsive-compulsive behaviours in Parkinson's disease? In: MOVEMENT DISORDERS. (pp. S464 - S465).

Olsson, B; Malmeström, C; Basun, H; Annas, P; Höglund, K; Lannfelt, L; ... Blennow, K; + view all (2012) Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials. J Alzheimers Dis , 32 (2) 273 - 276. 10.3233/JAD-2012-120931.

Ozawa, T; Revesz, T; Paviour, D; Lees, AJ; Quinn, N; Tada, M; ... Holton, JL; + view all (2012) Difference in MSA Phenotype Distribution between Populations: Genetics or Environment? J Parkinsons Dis , 2 (1) 7 - 18. 10.3233/JPD-2012-11056.

P

Paisán-Ruiz, C; Li, A; Schneider, SA; Holton, JL; Johnson, R; Kidd, D; ... Houlden, H; + view all (2012) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging , 33 (4) 814 - 823. 10.1016/j.neurobiolaging.2010.05.009.

Palmqvist, S; Hertze, J; Minthon, L; Wattmo, C; Zetterberg, H; Blennow, K; ... Hansson, O; + view all (2012) Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study. PLoS One , 7 (6) , Article e38639. 10.1371/journal.pone.0038639. Green and gold open access
file

Pandraud, A; Clayton, P; Foley, AR; Muntoni, F; Johnson, JO; Singleton, AB; ... Houlden, H; + view all (2012) INVESTIGATION OF RIBOFLAVIN TRANSPORTER MUTATIONS IN BROWN-VIALETTO-VAN LAERE SYNDROME, A POTENTIALLY TREATABLE METABOLIC DISEASE. JOURNAL OF INHERITED METABOLIC DISEASE , 35 S18 - S18.

Pandraud, A; Johnson, JO; Singleton, AB; Clayton, P; Land, J; Hargreaves, I; ... Houlden, H; + view all (2012) Genetic and functional investigation of Brown-Vialetto-Van Laere syndrome and related neuropathies. In: NEUROMUSCULAR DISORDERS. (pp. S19 - S20).

Papadopoulou, AS; Dooley, J; Linterman, MA; Pierson, W; Ucar, O; Kyewski, B; ... Liston, A; + view all (2012) The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptor. Nat Immunol , 13 (2) 181 - 187. 10.1038/ni.2193.

Papkovskaia, TD; Chau, KY; Inesta-Vaquera, F; Papkovsky, DB; Healy, DG; Nishio, K; ... Cooper, JM; + view all (2012) G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization. Hum Mol Genet , 21 (19) 4201 - 4213. 10.1093/hmg/dds244. Gold open access

Parén, L; Palmqvist, L; Barkhordar, GS; Hellgren, M; Zetterberg, H; (2012) Pregnancy and a rare MTHFR haplotype. Acta Obstet Gynecol Scand , 91 (5) 635 - 636. 10.1111/j.1600-0412.2012.01380.x.

Parkinson, MH; Nethisinghe, S; Clayton, L; Vermeer, S; Chapple, JP; Reilly, M; ... Giunti, P; + view all (2012) Retinal changes in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) and other genetic ataxias. In: MOVEMENT DISORDERS. (pp. S190 - S190).

Patani, R; Chandran, S; (2012) Experimental and therapeutic opportunities for stem cells in multiple sclerosis. Int J Mol Sci , 13 (11) 14470 - 14491. 10.3390/ijms131114470.

Patani, R; Lewis, PA; Trabzuni, D; Puddifoot, CA; Wyllie, DJ; Walker, R; ... Ryten, M; + view all (2012) Investigating the utility of human embryonic stem cell-derived neurons to model ageing and neurodegenerative disease using whole-genome gene expression and splicing analysis. J Neurochem , 122 (4) 738 - 751. 10.1111/j.1471-4159.2012.07825.x.

Patani, R; Sibley, CR; Chandran, S; Ule, J; (2012) Using human pluripotent stem cells to study post-transcriptional mechanisms of neurodegenerative diseases. Brain Res , 1462 129 - 138. 10.1016/j.brainres.2011.12.057.

Paudel, R; Hardy, J; Revesz, T; Holton, JL; Houlden, H; (2012) Review: Genetics and neuropathology of primary pure dystonia. Neuropathology and Applied Neurobiology , 38 (6) 520 - 534. 10.1111/j.1365-2990.2012.01298.x.

Paudel, R; Hardy, J; Revesz, T; Holton, JL; Houlden, H; (2012) Review: genetics and neuropathology of primary pure dystonia. Neuropathol Appl Neurobiol , 38 (6) 520 - 534. 10.1111/j.1365-2990.2012.01298.x.

Paudel, R; Revesz, T; Hardy, J; Holton, J; Houlden, H; (2012) Genetics and neuropathology of focal dystonia. In: MOVEMENT DISORDERS. (pp. S354 - S355).

Peall, K; Waite, A; Kurian, M; Wardle, M; Hedderly, T; Lin, JP; ... Morris, H; + view all (2012) Myoclonus dystonia syndrome: SGCE mutations and psychiatric disease. In: JOURNAL OF NEUROLOGY. (pp. S30 - S30).

Peall, K; Waite, AJ; Kurian, MA; Hedderly, T; Smith, M; Lin, JP; ... Morris, HR; + view all (2012) MYOCLONUS DYSTONIA: A CLINICAL AND GENETIC DESCRIPTION. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Petkova, VI; Zetterberg, H; Ehrsson, HH; (2012) Rubber hands feel touch, but not in blind individuals. PLoS One , 7 (4) , Article e35912. 10.1371/journal.pone.0035912. Green and gold open access
file

Petrovic, IN; Ling, H; Asi, Y; Ahmed, Z; Kukkle, PL; Hazrati, LN; ... Lees, AJ; + view all (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord , 27 (9) 1186 - 1190. 10.1002/mds.25115.

Piceathly, RDS; Smith, C; Fratter, C; Blakely, EL; Alston, CL; Deschauer, M; ... Gorman, GS; + view all (2012) Expanding the phenotypic and genotypic spectrum of adult RRM2B-related mitochondrial disease. In: NEUROMUSCULAR DISORDERS. (pp. S23 - S23).

Pillai, A; Bruno, D; Sarreal, AS; Hernando, RT; Saint-Louis, LA; Nierenberg, J; ... Buckley, PF; + view all (2012) Plasma BDNF levels vary in relation to body weight in females. PLoS One , 7 (7) , Article e39358. 10.1371/journal.pone.0039358. Green and gold open access
file

Pitceathly, RD; Murphy, SM; Cottenie, E; Chalasani, A; Sweeney, MG; Woodward, C; ... Hanna, MG; + view all (2012) Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. In: Neurology. (pp. 1145 - 1154).

Pitceathly, RD; Rahman, S; Hanna, MG; (2012) Single deletions in mitochondrial DNA--molecular mechanisms and disease phenotypes in clinical practice. Neuromuscular Disorders , 22 (7) 577 - 586. 10.1016/j.nmd.2012.03.009. Green and gold open access
file

Pitceathly, RD; Smith, C; Fratter, C; Alston, CL; He, L; Craig, K; ... Gorman, GS; + view all (2012) Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics. Brain , 135 (11) 3392 -3403. 10.1093/brain/aws231. Green and gold open access
file

Pitceathly, RDS; Murphy, SM; Cottenie, E; Chalasani, A; Sweeney, MG; Woodward, C; ... Hanna, MG; + view all (2012) Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. NEUROLOGY , 79 (11) 1145 - 1154.

Pitceathly, RDS; Tomlinson, SE; Hargreaves, I; Bhardwaj, N; Holton, JL; Evans, J; ... Rahman, S; + view all (2012) NOVEL DOMINANT POLG MUTATIONS CAUSE DISTAL MYOPATHY. In: JOURNAL OF INHERITED METABOLIC DISEASE. (pp. S119 - S119).

Pittman, A; Mencacci, N; Sheerin, U; Charlesworth, G; Deborah, H; Haworth, A; ... Lees, A; + view all (2012) A comprehensive diagnostic test for familial and early onset Parkinson's disease based on next-generation sequencing. In: JOURNAL OF MEDICAL GENETICS. (pp. S122 - S122).

Plagnol, V; Curtis, J; Epstein, M; Mok, KY; Stebbings, E; Grigoriadou, S; ... Nejentsev, S; + view all (2012) A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics , 28 (21) 2747 - 2754. 10.1093/bioinformatics/bts526. Gold open access
filefile

Plun-Favreau, H; Burchell, VS; Holmström, KM; Yao, Z; Deas, E; Cain, K; ... Abramov, AY; + view all (2012) HtrA2 deficiency causes mitochondrial uncoupling through the F₁F₀-ATP synthase and consequent ATP depletion. Cell Death and Disease , 3 , Article e335. 10.1038/cddis.2012.77. Green and gold open access
file

Politis, M; Loane, C; Wu, K; O'Sullivan, S; Woodhead, Z; Kiferle, L; ... Piccini, P; + view all (2012) Neural correlates of hypersexuality in Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S250 - S250).

Polke, J; Mencacci, N; Stamelou, M; Sweeney, MG; Manji, H; Wood, NW; ... Houlden, H; + view all (2012) Transcript analysis of a variably-penetrant GTP cyclohydrolase intronic splicing mutation. In: JOURNAL OF MEDICAL GENETICS. (pp. S92 - S92).

Polke, J; Mok, K; Poulter, M; Lashley, T; Beck, J; Wood, NW; ... Houlden, H; + view all (2012) Diagnostic testing for the frontotemporal dementia/amyotrophic lateral sclerosis (GGGGCC)n expansion in C9orf72. In: JOURNAL OF MEDICAL GENETICS. (pp. S122 - S122).

Pomara, N; Bruno, D; Sarreal, AS; Hernando, RT; Nierenberg, J; Petkova, E; ... Blennow, K; + view all (2012) Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am J Psychiatry , 169 (5) 523 - 530.

Portelius, E; Gustavsson, MK; Zetterberg, H; Andreasson, U; Blennow, K; (2012) Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient. Neurodegener Dis , 10 (1-4) 138 - 140. 10.1159/000334537.

Portelius, E; Zetterberg, H; Dean, RA; Marcil, A; Bourgeois, P; Nutu, M; ... Bateman, RJ; + view all (2012) Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease. J Alzheimers Dis , 31 (2) 335 - 341. 10.3233/JAD-2012-120508.

Pradeepa, MM; Sutherland, HG; Ule, J; Grimes, GR; Bickmore, WA; (2012) Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing. PLoS Genetics , 8 (5) , Article e1002717 . 10.1371/journal.pgen.1002717. Green and gold open access
file

Pressey, SN; Smith, DA; Wong, AM; Platt, FM; Cooper, JD; (2012) Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice. Neurobiology of Disease , 45 (3) 1086 - 1100. 10.1016/j.nbd.2011.12.027. Green and gold open access
file

Preza, E; Wray, S; Mahoney, C; Ryan, N; Liang, Y; Isaacs, A; ... Rossor, M; + view all (2012) Creation of a Fibroblast Resource for Dementia Research. In: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. (pp. 65 - 65).

Proukakis, C; Katsianou, M; Hummel, A; Brier, T; Houlden, H; Cooper, JM; Schapira, AH; (2012) A Novel Alpha-Synuclein Missense Mutation in Parkinson's Disease. In: ANNALS OF NEUROLOGY. (pp. S130 - S130).

Proukakis, C; Moore, D; Labrum, R; Wood, NW; Houlden, H; (2012) HEREDITARY SPASTIC PARAPLEGIA CAUSED BY SPASTIN (SPAST, SPG4) MUTATIONS IS FOUND MORE OFTEN IN MALES: REPORT OF NOVEL MUTATIONS FROM ONE CENTRE, AND REVIEW OF PUBLISHED LITERATURE. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Pulkes, T; Dejthevaporn, C; Apiwattanakul, M; Papsing, C; Hanna, MG; (2012) Paroxysmal neuromyotonia: A new sporadic channelopathy. NEUROMUSCULAR DISORDERS , 22 (6) 479 - 482. 10.1016/j.nmd.2012.01.004. Green and gold open access
file

R

Raheem, O; Penttila, S; Suominen, T; Kaakinen, M; Burge, J; Haworth, A; ... Udd, B; + view all (2012) New immunohistochemical method for improved myotonia and chloride channel mutation diagnostics. In: NEUROMUSCULAR DISORDERS. (pp. 898 - 898).

Raheem, O; Penttilä, S; Suominen, T; Kaakinen, M; Burge, J; Haworth, A; ... Udd, B; + view all (2012) New immunohistochemical method for improved myotonia and chloride channel mutation diagnostics. Neurology , 79 (22) 2194 - 2200. 10.1212/WNL.0b013e31827595e2.

Raja Rayan, DL; Haworth, A; Sud, R; Matthews, E; Fialho, D; Burge, J; ... Hanna, MG; + view all (2012) A new explanation for recessive myotonia congenita: exon deletions and duplications in CLCN1. Neurology , 78 (24) 1953 - 1958. 10.1212/WNL.0b013e318259e19c. Gold open access

Rajakulendran, S; Kaski, D; Hanna, MG; (2012) Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol , 8 (2) 86 - 96. 10.1038/nrneurol.2011.228.

Rajakulendran, S; Stewart, H; Koltzenburg, M; Hanna, MG; (2012) DELETION OF THE POTASSIUM CHANNEL GENE KCNC2 IN A FAMILY WITH NEURODEVELOPMENTAL DELAY AND ATAXIA. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Rayan, DLR; Matthews, E; Barreto, G; Tan, SV; Dewar, L; Burge, J; ... Grp, CINCH; + view all (2012) Efficacy of mexiletine in non-dystrophic myotonia: results of an international multi-centred randomised controlled trial. In: NEUROMUSCULAR DISORDERS. (pp. S4 - S4).

Rayan, DR; Barohn, RJ; Bundy, B; Wang, Y; Herbelin, L; Trivedi, J; ... Grp, CINCHS; + view all (2012) MEXILETINE IS AN EFFECTIVE TREATMENT IN NON-DYSTROPHIC MYOTONIA. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Rayan, DR; Haworth, A; Sud, R; Matthews, E; Fialho, D; Burge, J; ... Hanna, MG; + view all (2012) SKELETAL MUSCLE CHLORIDE CHANNEL GENE (CLCN1) COPY NUMBER VARIATION CAN CAUSE MYOTONIA CONGENITA. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Rayan, DR; Haworth, A; Sud, R; McCall, S; Tan, SV; Durran, S; ... Hanna, MG; + view all (2012) IDENTIFYING THE CAUSE OF PHENOTYPIC VARIABILITY IN A FAMILY WITH NON-DYSTROPHIC MYOTONIA. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Reinsfelt, B; Ricksten, SE; Zetterberg, H; Blennow, K; Fredén-Lindqvist, J; Westerlind, A; (2012) Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery. Ann Thorac Surg , 94 (2) 549 - 555. 10.1016/j.athoracsur.2012.04.044.

Reinsfelt, B; Westerlind, A; Ioanes, D; Zetterberg, H; Fredén-Lindqvist, J; Ricksten, SE; (2012) Transcranial Doppler microembolic signals and serum marker evidence of brain injury during transcatheter aortic valve implantation. Acta Anaesthesiol Scand , 56 (2) 240 - 247. 10.1111/j.1399-6576.2011.02563.x.

Reza, M; Johnson, D; Cox, D; Laval, S; Chaouch, A; Barresi, R; ... Lochmueller, H; + view all (2012) MRC NMD Centre Biobank: An overview. In: NEUROMUSCULAR DISORDERS. (pp. S34 - S34).

Ricotti, V; Engledow, E; Emmanuel, A; Knowles, J; Walker, D; Giordano, P; ... Quinlivan, R; + view all (2012) Recurrent pseudo-obstruction and sigmoid volvulus in Duchenne Muscular Dystrophy: A case report. In: NEUROMUSCULAR DISORDERS. (pp. 887 - 888).

Ricotti, V; Scoto, M; Mandy, WPL; Entwistle, K; Robb, SA; Mercuri, E; ... Muntoni, F; + view all (2012) Neurobehavioural disorders in Duchenne Muscular Dystrophy. In: NEUROMUSCULAR DISORDERS. (pp. 887 - 887).

Rogelj, B; Easton, LE; Bogu, GK; Stanton, LW; Rot, G; Curk, T; ... Ule, J; + view all (2012) Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci Rep , 2 603 - ?. 10.1038/srep00603. Gold open access

Rogers, I; Kerr, F; Martinez, P; Hardy, J; Lovestone, S; Partridge, L; (2012) Ageing increases vulnerability to aβ42 toxicity in Drosophila. PLOS One , 7 (7) , Article e40569. 10.1371/journal.pone.0040569. Green and gold open access
file

Rogers, K; Felsenstein, KM; Hrdlicka, L; Tu, Z; Albayya, F; Lee, W; ... Koenig, G; + view all (2012) Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice. Mol Neurodegener , 7 61 - ?. 10.1186/1750-1326-7-61.

Rolstad, S; Berg, AI; Zetterberg, H; Johansson, B; Wallin, A; (2012) All cognitive systems but speed and visuospatial functions reduce the effect of CSF pathology on other systems. Curr Alzheimer Res , 9 (9) 1043 - 1049.

Rosén, C; Andreasson, U; Mattsson, N; Marcusson, J; Minthon, L; Andreasen, N; ... Zetterberg, H; + view all (2012) Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease. Neuromolecular Med , 14 (1) 65 - 73. 10.1007/s12017-012-8171-4.

Rossor, AM; Davidson, G; Houlden, HH; Kalmar, B; Greensmith, L; Reilly, MM; (2012) A novel p.glu175x premature stop mutation in the C-terminal end of HSP27 is a cause of CMT2. In: NEUROMUSCULAR DISORDERS. (pp. S21 - S21).

Rossor, AM; Davidson, GL; Blake, J; Polke, JM; Murphy, SM; Houlden, H; ... Reilly, MM; + view all (2012) A novel p.Glu175X premature stop mutation in the C-terminal end of HSP27 is a cause of CMT2. J Peripher Nerv Syst , 17 (2) 201 - 205. 10.1111/j.1529-8027.2012.00400.x.

Rossor, AM; Houlden, H; Reilly, MM; (2012) A Clinical Study of the Distal Hereditary Motor Neuropathies. In: ANNALS OF NEUROLOGY. (pp. S76 - S76).

S

Sailer, A; Houlden, H; (2012) Recent advances in the genetics of cerebellar ataxias. Curr Neurol Neurosci Rep , 12 (3) 227 - 236. 10.1007/s11910-012-0267-6.

Sailer, A; Scholz, SW; Gibbs, JR; Tucci, A; Johnson, JO; Wood, NW; ... Houlden, H; + view all (2012) Exome sequencing in an SCA14 family demonstrates its utility in diagnosing heterogeneous diseases. Neurology , 79 (2) 127 - 131. 10.1212/WNL.0b013e31825f048e. Gold open access

Salta, E; De Strooper, B; (2012) Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol , 11 (2) 189 - 200. 10.1016/S1474-4422(11)70286-1.

Sanotsky, Y; Selikhova, M; Fedorishin, L; Matvienko, Y; Komnatska, I; Grey, H; ... Lees, AJ; + view all (2012) Update on ephedrone induced parkinsonism with dystonia: Four year follow up. In: MOVEMENT DISORDERS. (pp. S393 - S394).

Söderqvist, F; Carlberg, M; Zetterberg, H; Hardell, L; (2012) Use of wireless phones and serum β-trace protein in randomly recruited persons aged 18-65 years: a cross-sectional study. Electromagn Biol Med , 31 (4) 416 - 424. 10.3109/15368378.2012.683224.

Scharf, J; Yu, D; Mathews, C; Neale, B; Stewart, E; Fagerness, J; ... Pauls, D; + view all (2012) Genome-Wide Association Study of Gilles de la Tourette Syndrome. In: NEUROLOGY.

Schneider, SA; Hardy, J; Bhatia, KP; (2012) Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations. Mov Disord , 27 (1) 42 - 53. 10.1002/mds.23971.

Schneider, SA; Mummery, CJ; Mehrabian, M; Houlden, H; Bain, PG; (2012) Hereditary spastic paraplegia, thin corpus callosum and tremor. In: MOVEMENT DISORDERS. (pp. S420 - S420).

Schneider, SA; Mummery, CJ; Mehrabian, M; Houlden, H; Bain, PG; (2012) SPG11 Presenting with Tremor. Tremor Other Hyperkinet Mov (N Y) , 2

Schor, IE; Lleres, D; Risso, GJ; Pawellek, A; Ule, J; Lamond, AI; Kornblihtt, AR; (2012) Perturbation of chromatin structure globally affects localization and recruitment of splicing factors. PLoS One , 7 (11) , Article e48084 . 10.1371/journal.pone.0048084. Green and gold open access
file

Schottlaender, LV; Mencacci, N; Koepp, M; Hanna, M; Hardy, J; Lees, AJ; Houlden, H; (2012) Interesting clinical features associated with mutations in the SLC20A2 gene. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 40 - 40).

Schottlaender, LV; Sailer, A; Tucci, A; Mok, K; Ling, H; Plagnol, V; ... Houlden, H; + view all (2012) Exome sequencing in familial multiple system atrophy. In: MOVEMENT DISORDERS. (pp. S468 - S468).

Seow, Y; Sibley, CR; Wood, MJ; (2012) Artificial mirtron-mediated gene knockdown: functional DMPK silencing in mammalian cells. RNA , 18 (7) 1328 - 1337. 10.1261/rna.030601.111.

Seppälä, TT; Nerg, O; Koivisto, AM; Rummukainen, J; Puli, L; Zetterberg, H; ... Herukka, SK; + view all (2012) CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology , 78 (20) 1568 - 1575. 10.1212/WNL.0b013e3182563bd0.

Setó-Salvia, N; Pagonabarraga, J; Houlden, H; Pascual-Sedano, B; Dols-Icardo, O; Tucci, A; ... Clarimón, J; + view all (2012) Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course. Mov Disord , 27 (3) 393 - 399. 10.1002/mds.24045.

Setó-Salvia, N; Sánchez-Quinto, F; Carbonell, E; Lorenzo, C; Comas, D; Clarimón, J; (2012) Using the neanderthal and denisova genetic data to understand the common MAPT 17q21 inversion in modern humans. Hum Biol , 84 (6) 633 - 640.

Sheerin, U-M; Charlesworth, G; Bras, J; Guerreiro, R; Wood, N; Bhatia, K; ... Lees, A; + view all (2012) Screening for VPS35 mutations in Parkinson's disease. Neurobiology of Aging , 33 (4) 10.1016/j.neurobiolaging.2011.10.032.

Sheerin, UM; Charlesworth, G; Bras, J; Guerreiro, R; Bhatia, K; Foltynie, T; ... Wood, N; + view all (2012) Screening for VPS35 mutations in Parkinson's disease. Neurobiol Aging , 33 (4) 838.e1 - 838.e5. 10.1016/j.neurobiolaging.2011.10.032.

Sibley, CR; Attig, J; Ule, J; (2012) The greatest catch: big game fishing for mRNA-bound proteins. Genome Biol , 13 (7) 163 - ?. 10.1186/gb4030.

Sibley, CR; Seow, Y; Curtis, H; Weinberg, MS; Wood, MJ; (2012) Silencing of Parkinson's disease-associated genes with artificial mirtron mimics of miR-1224. Nucleic Acids Res , 40 (19) 9863 - 9875. 10.1093/nar/gks712.

Sibley, CR; Seow, Y; Saayman, S; Dijkstra, KK; El Andaloussi, S; Weinberg, MS; Wood, MJ; (2012) The biogenesis and characterization of mammalian microRNAs of mirtron origin. Nucleic Acids Res , 40 (1) 438 - 448. 10.1093/nar/gkr722.

Siebert, M; Donis, KC; Socal, M; Rieder, CRM; Emmel, VE; Vairo, F; ... Jardim, LB; + view all (2012) Glucocerebrosidase gene variants in parkinsonian patients with Machado Joseph/spinocerebellar ataxia 3. Parkinsonism & Related Disorders , 18 (2) 185 - 190. 10.1016/j.parkreldis.2011.09.024.

Silveira-Moriyama, L; Kingsbury, A; Ayling, H; Holton, JL; Sterlacci, W; Petrie, A; ... Lees, AJ; + view all (2012) Availability of olfactory bulb and olfactory tract in brain specimens in a brain bank. In: MOVEMENT DISORDERS. (pp. S518 - S518).

Silveira-Moriyama, L; Lees, AJ; (2012) Pulo do gato. Arquivos de Neuro-Psiquiatria , 70 (4) 245 - 245. Gold open access

Simon-Sanchez, J; Kilarski, LL; Nalls, MA; Martinez, M; Schulte, C; Holmans, P; ... Consor, WTCC; + view all (2012) Cooperative Genome-Wide Analysis Shows Increased Homozygosity in Early Onset Parkinson's Disease. PLOS ONE , 7 (3) , Article e28787. 10.1371/journal.pone.0028787. Green and gold open access
file

Sinclair, CD; Morrow, JM; Fischmann, A; Hanna, MG; Reilly, MM; Yousry, TA; ... Thornton, JS; + view all (2012) Novel muscle fat-fraction MRI metrics for quantifying neuromuscular pathology. In: NEUROMUSCULAR DISORDERS. (pp. S33 - S33).

Sinclair, CD; Morrow, JM; Hanna, MG; Reilly, MM; Yousry, TA; Golay, X; Thornton, JS; (2012) Correcting radiofrequency inhomogeneity effects in skeletal muscle magnetisation transfer maps. NMR Biomed , 25 (2) 262 - 270. 10.1002/nbm.1744.

Sinclair, CD; Morrow, JM; Miranda, MA; Davagnanam, I; Cowley, PC; Mehta, H; ... Thornton, JS; + view all (2012) Skeletal muscle MRI magnetisation transfer ratio reflects clinical severity in peripheral neuropathies. J Neurol Neurosurg Psychiatry , 83 (1) 29 - 32. 10.1136/jnnp.2011.246116.

Sinclair, CDJ; Morrow, JM; Hanna, MG; Koltzenburg, M; Yousry, TA; Reilly, MM; ... Mehta, H; + view all (2012) Skeletal muscle MRI magnetisation transfer ratio reflects clinical severity in peripheral neuropathies. Journal of Neurology, Neurosurgery and Psychiatry , 83 (1) 29 - 32. 10.1136/jnnp.2011.246116.

Sinclair, CDJ; Morrow, JM; Hanna, MG; Reilly, MM; Yousry, TA; Thornton, JS; Golay, X; (2012) Correcting radiofrequency inhomogeneity effects in skeletal muscle magnetisation transfer maps. NMR in Biomedicine , 25 (2) 262 - 270. 10.1002/nbm.1744.

Slemmon, JR; Meredith, J; Guss, V; Andreasson, U; Andreasen, N; Zetterberg, H; Blennow, K; (2012) Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects. J Neurochem , 120 (2) 325 - 333. 10.1111/j.1471-4159.2011.07553.x.

Soreq, L; Ben-Shaul, Y; Israel, Z; Bergman, H; Soreq, H; (2012) Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways. Neurobiology of Disease , 45 (3) 1018 - 1030. 10.1016/j.nbd.2011.12.021.

Soreq, L; Bergman, H; Goll, Y; Greenberg, DS; Israel, Z; Soreq, H; (2012) Deep brain stimulation induces rapidly reversible transcript changes in Parkinson's leucocytes. Journal of Cellular and Molecular Medicine , 16 (7) 1496 - 1507. 10.1111/j.1582-4934.2011.01444.x.

Soreq, L; Bergman, H; Israel, Z; Soreq, H; (2012) Exon Arrays Reveal Alternative Splicing Aberrations in Parkinson’s Disease Leukocytes. Neurodegenerative Diseases , 10 (1-4) 203 - 206. 10.1159/000332598.

Stamelou, M; Mencacci, N; Cordivari, C; Batla, A; Houlden, H; Wood, N; ... Bhatia, K; + view all (2012) Myoclonic dystonia syndrome due to tyrosine hydroxylase deficiency. In: MOVEMENT DISORDERS. (pp. S201 - S201).

Stamelou, M; Mencacci, NE; Cordivari, C; Batla, A; Wood, NW; Houlden, H; ... Bhatia, KP; + view all (2012) Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency. Neurology , 79 (5) 435 - 441. 10.1212/WNL.0b013e318261714a. Gold open access

Statland, J; Salajegheh, M; Bundy, B; Wang, Y; Rayan, DR; Trivedi, J; ... Invest, CC; + view all (2012) Phase II Therapeutic Trial of Mexiletine in Non-Dystrophic Myotonia: Secondary Outcomes Show Improvement in Symptoms and Signs of Myotonia. In: NEUROLOGY.

Statland, JM; Bundy, BN; Wang, Y; Rayan, DR; Trivedi, JR; Sansone, VA; ... Consortium for Clinical Investigation of Neurologic Channelopathies,; + view all (2012) Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial. JAMA , 308 (13) 1357 - 1365. 10.1001/jama.2012.12607.

Statland, JM; Bundy, BN; Wang, Y; Rayan, DR; Trivedi, JR; Sansone, VA; ... Consortium for Clinical Investigation of Neurologic Channelopathies,; + view all (2012) Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial. JAMA , 308 (13) 1357 - 1365. 10.1001/jama.2012.12607.

Statland, JM; Bundy, BN; Wang, Y; Trivedi, JR; Raja Rayan, D; Herbelin, L; ... CINCH Consortium,; + view all (2012) A quantitative measure of handgrip myotonia in non-dystrophic myotonia. Muscle Nerve , 46 (4) 482 - 489. 10.1002/mus.23402.

Stein, JL; Medland, SE; Vasquez, AA; Hibar, DP; Senstad, RE; Winkler, AM; ... Enhancing Neuro Imaging Genetics through Meta-Analysis Consortium,; + view all (2012) Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet , 44 (5) 552 - 561. 10.1038/ng.2250.

Stein, JL; Medland, SE; Vasquez, AA; Hibar, DP; Senstad, RE; Winkler, AM; ... Enhancing Neuro Imaging Genetics through Meta-Analysis Consortium,; + view all (2012) Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet , 44 (5) 552 - 561. 10.1038/ng.2250.

Stevens, J; Murphy, SM; Davagnanam, I; Phadke, R; Bremner, F; Anderson, G; ... Reilly, MM; + view all (2012) ARSACS: A NOVEL PHENOTYPE CAUSING PERIPHERAL NEUROPATHY, ATAXIA AND SPASTICITY WITH SUPRANUCLEAR GAZE PALSY, MYOCLONUS AND EPILEPSY. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY.

Stockner, H; Schwingenschuh, P; Djamshidian, A; Silveira-Moriyama, L; Katschnig, P; Seppi, K; ... Bhatia, KP; + view all (2012) Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease? Movement Disorders , 27 (9) 1182 - 1185. 10.1002/mds.25102. Green and gold open access
file

Stomrud, E; Forsberg, A; Hägerström, D; Ryding, E; Blennow, K; Zetterberg, H; ... Londos, E; + view all (2012) CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly. Dement Geriatr Cogn Disord , 33 (2-3) 156 - 163. 10.1159/000338185.

Strange, A; Riley, BP; Spencer, CCA; Morris, DW; Pirinen, M; O'Dushlaine, CT; ... Consor, WTCC; + view all (2012) Genome-Wide Association Study Implicates HLA-C*01:02 as a Risk Factor at the Major Histocompatibility Complex Locus in Schizophrenia. BIOLOGICAL PSYCHIATRY , 72 (8) 620 - 628. 10.1016/j.biopsych.2012.05.035.

Sugimoto, Y; König, J; Hussain, S; Zupan, B; Curk, T; Frye, M; Ule, J; (2012) Analysis of CLIP and iCLIP methods for nucleotide-resolution studies of protein-RNA interactions. Genome Biol , 13 (8) R67 - ?. 10.1186/gb-2012-13-8-r67.

Sundal, C; Ekholm, S; Nordborg, C; Jönsson, L; Börjesson-Hanson, A; Lindén, T; ... Andersen, O; + view all (2012) Update of the original HDLS kindred: divergent clinical courses. Acta Neurol Scand , 126 (1) 67 - 75. 10.1111/j.1600-0404.2011.01624.x.

Swaminathan, S; Huentelman, MJ; Corneveaux, JJ; Myers, AJ; Faber, KM; Foroud, T; ... Grp, NIA-LOADNCRADFS; + view all (2012) Analysis of Copy Number Variation in Alzheimer's Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals. PLOS ONE , 7 (12) , Article e50640. 10.1371/journal.pone.0050640. Green and gold open access
file

T

Taba, P; Lees, AJ; Stern, G; (2012) Erich Harnack and apomorphine: An historical insight. In: MOVEMENT DISORDERS. (pp. S88 - S88).

Tan, SV; Z'graggen, WJ; Boërio, D; Rayan, DL; Howard, R; Hanna, MG; Bostock, H; (2012) Membrane dysfunction in Andersen-Tawil syndrome assessed by velocity recovery cycles. Muscle Nerve , 46 (2) 193 - 203. 10.1002/mus.23293.

Teive, HAG; Germiniani, FMB; Munhoz, RP; Lees, AJ; (2012) Cartas de Dom Pedro II para o professor Brown-Séquard: Correspondência imperial e neurofisiologia. Arquivos de Neuro-Psiquiatria , 70 (8) 633 - 636. 10.1590/S0004-282X2012000800014. Gold open access

Teive, HAG; Germiniani, FMB; Munhoz, RP; Lees, AJ; (2012) Letters from Dom Pedro II to professor Brown-Sequard: imperial correspondence and neurophysiology. ARQUIVOS DE NEURO-PSIQUIATRIA , 70 (8) 633 - 636. Gold open access

Thomson, SR; Wishart, TM; Patani, R; Chandran, S; Gillingwater, TH; (2012) Using induced pluripotent stem cells (iPSC) to model human neuromuscular connectivity: promise or reality? J Anat , 220 (2) 122 - 130. 10.1111/j.1469-7580.2011.01459.x.

Tollervey, J; Ule, J; (2012) The CLIP Method to Study Protein-RNA Interactions in Intact Cells and Tissues. Alternative pre-mRNA Splicing: Theory and Protocols 268 - 278. 10.1002/9783527636778.ch25.

Tomlinson, SE; Bostock, H; Grinton, B; Hanna, MG; Kullmann, DM; Kiernan, MC; ... Burke, D; + view all (2012) In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission. BRAIN , 135 3144 - 3152. 10.1093/brain/aws241.

Trabzuni, D; Ryten, M; Walker, R; Smith, C; Imran, S; Ramasamy, A; ... Hardy, J; + view all (2012) Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies (vol 119, pg 275, 2011). JOURNAL OF NEUROCHEMISTRY , 120 (3) 473 - 473. 10.1111/j.1471-4159.2011.07602.x.

Trabzuni, D; Wray, S; Vandrovcova, J; Ramasamy, A; Walker, R; Smith, C; ... Ryten, M; + view all (2012) MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Human Molecular Genetics , 21 (18) 4094 -4103. 10.1093/hmg/dds238. Green and gold open access
filefilefile

Trancikova, A; Mamais, A; Webber, PJ; Stafa, K; Tsika, E; Glauser, L; ... Moore, DJ; + view all (2012) Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations. PLoS One , 7 (10) , Article e47784 . 10.1371/journal.pone.0047784. Green and gold open access
file

Trivedi, J; Bundy, B; Rayan, DR; Salajegheh, M; Statland, J; Venance, S; ... Barohn, R; + view all (2012) Clinical and Molecular Characterization of Non-Dystrophic Myotonia. In: NEUROLOGY.

Tsoi, LC; Spain, SL; Knight, J; Ellinghaus, E; Stuart, PE; Capon, F; ... Trembath, RC; + view all (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet , 44 (12) 1341 - 1348. 10.1038/ng.2467.

Tsoi, LC; Spain, SL; Knight, J; Ellinghaus, E; Stuart, PE; Capon, F; ... Trembath, RC; + view all (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet , 44 (12) 1341 - 1348. 10.1038/ng.2467.

Tucci, A; Charlesworth, G; Sheerin, UM; Plagnol, V; Wood, NW; Hardy, J; (2012) Study of the genetic variability in a Parkinson's Disease gene: EIF4G1. Neurosci Lett , 518 (1) 19 - 22. 10.1016/j.neulet.2012.04.033. Green and gold open access
file

V

Vale, TC; Lees, A; Cardoso, F; (2012) Gower's Queen Square case notes on chorea. In: MOVEMENT DISORDERS. (pp. S88 - S88).

van der Heijde, D; Machado, P; Braun, J; Hermann, KG; Baraliakos, X; Hsu, B; ... Landewé, R; + view all (2012) MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis , 71 (3) 369 - 373. 10.1136/annrheumdis-2011-200208.

Vandersteen, A; Masman, MF; De Baets, G; Jonckheere, W; van der Werf, K; Marrink, SJ; ... Broersen, K; + view all (2012) Molecular plasticity regulates oligomerization and cytotoxicity of the multipeptide-length amyloid-β peptide pool. J Biol Chem , 287 (44) 36732 - 36743. 10.1074/jbc.M112.394635.

Vilain, S; Esposito, G; Haddad, D; Schaap, O; Dobreva, MP; Vos, M; ... Verstreken, P; + view all (2012) The yeast complex I equivalent NADH dehydrogenase rescues pink1 mutants. PLoS Genetics , 8 (1) , Article e1002456. 10.1371/journal.pgen.1002456. Green and gold open access
file

Voermans, NC; Kleefstra, T; Gabreëls-Festen, AA; Faas, BH; Kamsteeg, EJ; Houlden, H; ... Reilly, MM; + view all (2012) Severe Dejerine-Sottas disease with respiratory failure and dysmorphic features in association with a PMP22 point mutation and a 3q23 microdeletion. J Peripher Nerv Syst , 17 (2) 223 - 225. 10.1111/j.1529-8027.2012.00402.x.

Vos, M; Esposito, G; Edirisinghe, JN; Vilain, S; Haddad, DM; Slabbaert, JR; ... Verstreken, P; + view all (2012) Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency. Science , 336 (6086) 1306 - 1310. 10.1126/science.1218632.

W

Wagnon, JL; Briese, M; Sun, W; Mahaffey, CL; Curk, T; Rot, G; ... Frankel, WN; + view all (2012) CELF4 regulates translation and local abundance of a vast set of mRNAs, including genes associated with regulation of synaptic function. PLoS Genet , 8 (11) , Article e1003067. 10.1371/journal.pgen.1003067. Green and gold open access
file

Wang, Y; He, J; McVey, A; Pasnoor, M; Gallagher, P; Herbelin, L; ... Dimachkie, M; + view all (2012) Twelve-Month Change of IBMFRS in the Arimocolomol Inclusion Body Myositis Pilot Study. In: NEUROLOGY.

Wanngren, J; Ottervald, J; Parpal, S; Portelius, E; Strömberg, K; Borgegård, T; ... Karlström, H; + view all (2012) Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ production. J Biol Chem , 287 (39) 32640 - 32650. 10.1074/jbc.M112.376541. Gold open access

Warren, JD; Rohrer, JD; Hardy, J; (2012) Disintegrating brain networks: from syndromes to molecular nexopathies. Neuron , 73 (6) 1060 - 1062. 10.1016/j.neuron.2012.03.006. Gold open access

Wharton, W; Stein, JH; Korcarz, C; Sachs, J; Olson, SR; Zetterberg, H; ... Carlsson, CM; + view all (2012) The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial. J Alzheimers Dis , 32 (1) 147 - 156. 10.3233/JAD-2012-120763.

Wittnam, JL; Portelius, E; Zetterberg, H; Gustavsson, MK; Schilling, S; Koch, B; ... Bayer, TA; + view all (2012) Pyroglutamate amyloid β (Aβ) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease. J Biol Chem , 287 (11) 8154 - 8162. 10.1074/jbc.M111.308601.

Woodward, C; Sweeney, MG; Pitceathly, RDS; Mudanohwo, EE; Hughes, D; Pittman, A; ... Hanna, MG; + view all (2012) Next Generation Sequencing as a potential diagnostic tool for mitochondrial DNA diseases. In: JOURNAL OF MEDICAL GENETICS. (pp. S116 - S116).

Wray, S; Murray, H; Preza, E; Drummond, NJ; Devine, MJ; Isaacs, A; ... Kunath, T; + view all (2012) Human Stem Cell Models of Frontotemporal Dementia Caused by a Non-Coding Hexanucleotide Repeat Expansion in C9orf72. In: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. (pp. 60 - 61).

Wray, S; Self, M; NINDS Parkinson's Disease iPSC Consortium,; NINDS Huntington's Disease iPSC Consortium,; NINDS ALS iPSC Consortium,; Lewis, PA; ... Hardy, J; + view all (2012) Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLOS One , 7 (8) , Article e43099. 10.1371/journal.pone.0043099. Green and gold open access
file

X

Xiromerisiou, G; Houlden, H; Kara, E; Hardy, J; Lees, AJ; Paudel, R; ... Scarmeas, N; + view all (2012) THAP1 mutations and dystonia phenotypes: Genotype phenotype correlations. Movement Disorders , 27 (10) 1290 - 1294. 10.1002/mds.25146.

Xiromerisiou, G; Houlden, H; Sailer, A; Silveira-Moriyama, L; Hardy, J; Lees, AJ; (2012) Identical twins with Leucine rich repeat kinase type 2 mutations discordant for Parkinson's disease. Mov Disord , 27 (10) 1323 - ?. 10.1002/mds.24924.

Xiromerisiou, G; Houlden, H; Scarmeas, N; Stamelou, M; Kara, E; Hardy, J; ... Bhatia, K; + view all (2012) THAP1 mutations and dystonia phenotypes: A metanalysis, genotype phenotype correlations and identification of novel mutations. In: MOVEMENT DISORDERS. (pp. S370 - S370).

Xiromerisiou, G; Houlden, H; Scarmeas, N; Stamelou, M; Kara, E; Hardy, J; ... Bhatia, KP; + view all (2012) THAP1 mutations and dystonia phenotypes: genotype phenotype correlations. Mov Disord , 27 (10) 1290 - 1294. 10.1002/mds.25146.

Xiromerisiou, G; Kara, E; Houlden, H; Tsironi, E; Dardiotis, E; Dardioti, M; Hadjigeorgiou, G; (2012) Identification of novel THAP1 sequence variants in patients with blepharospam. In: MOVEMENT DISORDERS. (pp. S473 - S473).

Z

Zadeh, G; Salehi, F; An, S; Revesz, T; Holton, J; Thom, M; ... Kitchen, N; + view all (2012) Diagnostic implications of histological analysis of neurosurgical aspirate in addition to routine resections. Neuropathology , 32 (1) 44 - 50. 10.1111/j.1440-1789.2011.01234.x.

Zadeh, G; Salehi, F; An, S; Uff, C; Camp, S; Revesz, T; ... Brandner, S; + view all (2012) Diagnostic implications of histological analysis of neurosurgical aspirate in addition to routine resections. Neuropathology , 32 (1) 44 - 50. 10.1111/j.1440-1789.2011.01234.x.

Zetterberg, H; Blennow, K; (2012) Cerebrospinal fluid biomarkers for Alzheimer's disease: More to come? Advances in Alzheimer's Disease , 3 361 - 369.

Zetterberg, H; Blennow, K; Hampel, H; (2012) Diagnostic tools: Fluid biomarkers for Alzheimer's disease. Advances in Biological Psychiatry , 28 71 - 79. 10.1159/000335385.

Zetterberg, H; Hammarström, P; (2012) Power tools for Alzheimer's disease - an electrochemical preamp for Aβ. J Neurochem , 122 (2) 231 - 232. 10.1111/j.1471-4159.2012.07730.x.

Zetterberg, H; Lunn, MP; Herukka, SK; (2012) Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease. Biomark Med , 6 (4) 371 - 376. 10.2217/bmm.12.47.

Zetterberg, H; Visser, PJ; (2012) Fluid biomarkers for Alzheimer's disease: standardization and recent developments. Biomark Med , 6 (4) 363 - 364. 10.2217/bmm.12.40.

Zhou, L; Barão, S; Laga, M; Bockstael, K; Borgers, M; Gijsen, H; ... De Strooper, B; + view all (2012) The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo (Journal of Biological Chemistry (2012) 287, (25927-25940)). Journal of Biological Chemistry , 287 (40) 33719 - 33719. 10.1074/jbc.A112.377465.

Zhou, L; Barão, S; Laga, M; Bockstael, K; Borgers, M; Gijsen, H; ... De Strooper, B; + view all (2012) The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo. J Biol Chem , 287 (31) 25927 - 25940. 10.1074/jbc.M112.377465.

This list was generated on Sun Nov 23 04:13:40 2014 GMT.